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SUMMARY
Cellular adhesion research has recently focused on the small scale at the level of 
individual receptor-ligand bonds. This trend in research is primarily due to experimental 
advances which allow such individual bond force measurements. Here, one of these 
techniques, micromanipulation, has been extended to not only determine the bond force 
of individual receptor-ligand pairs, but also the intrinsic kinetic rates of the interaction. 
Using transmembrane (TM ) Fc gamma receptor III (CD16a-TM) and human IgG (hIgG), 
the dependence of adhesion probability on receptor-ligand expression densities, contract 
duration and contact area was quantitated. A probabilistic based theoretical formulation 
was developed and validated that relates the intrinsic molecular kinetic rates of the 
receptor–ligand interaction to the experimentally determined adhesion probability. This 
theoretical formulation describing individual receptor-ligand kinetics has also allowed 
direct evaluation of existing biophysical bond strength/kinetics paradigms at the extreme 
condition of single bonds. A force-displacement model was also developed to quantitate 
the force exerted on the RBC membrane transducer during the micropipette retraction 
process and found to be in agreement with previous work.
In addition to CD16a-TM, the kinetic rates of CD16a anchored via a glycosyl 
phosphatidylinositol (GPI) moiety (CD16a-GPI) and the two alleles of CD16b (NA1 and 
NA2) were determined for human, rabbit, and mouse IgG species. The binding affinity of 
these CD16 interactions to soluble IgG was also measured by traditional bulk chemistry 
approaches and compared to those measured via the micromanipulation protocol in which 
the IgG ligand is membrane bound in the solid phase. These data suggest that the 
membrane anchor itself can alter CD16 binding properties. This represents the first 
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reported effect of the anchor on an intrinsic receptor property, its kinetic rates and 
binding affinity.
This thesis presents two specific aims or goals. These goals were achieved and 
reported in this thesis. During the course of this research, I also explored other directions 
and gathered initial data. These directions were further explored by other researchers but 
the initial data is also presented here. The areas of this initial research include:
1. The elucidation of receptor / ligand orientation effects on solid phase 
affinity. The orientation of molecules on the surface was shown to affect 
the effective molecular densities and therefore the on-rate and affinity of 
the interaction.
2. Defining a method for the determination of detachment mode during bond 
decoupling. A bond can break either by up rooting of the receptor from the 
attached membrane or between the receptor and ligand pair. The defined 
method describes a procedure to quantify the portion of each mode of 
detachment.
3. The characterization of CD16a-TM and hIgG bond force histograms for 
evidence of stochastic or deterministic behavior.
4. The observation of CD16 mediated phagocytosis at the single cell level 
utilizing the micropipette system.
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CHAPTER 1
GOALS, OBJECTIVES, SPECIFIC AIMS
The availability of isolated CD16 isoform cell lines and the micropipette 
experimental system for isolating cellular contact provide for the opportunistic 
exploration of small scale adhesion analysis. The availability of CD16 in the receptor / 
ligand model is fortunate. CD16 is natively expressed in three different isoforms. The 
effect of the different isoforms on binding is previously not known and with elucidation 
is directly relevant to biological processes. The CD16 ligand is the Fc portion of IgG. The 
use of IgG also permits the affinities of the adhesion components to be easily 
manipulated by altering the species of IgG used in the analysis. Using the CD16, IgG and 
micropipette system the specific goals and objectives of this work are as follows:
Develop A Method For The Determination Of Solid Phase Kinetic Properties Using 
The Micropipette Experimental System In Small Scale Adhesion.
Previous experiments utilizing micromanipulation with red blood cells (RBC) for 
the determination of bonding forces utilized antibody coated beads or crosslinking 
antibodies. The experiments reported here utilized a transfected Chinese Hamster Ovary 
(CHO) cell line expressing CD16 and a RBC expressing IgG. In order to examine small 
scale adhesion using the micropipette experimental system a theoretical framework must 
first be developed. Previous explorations into small scale adhesion focused mainly on the 
resolution of force. The determination of the solid phase kinetics of small scale binding 
will require a new model. This model will first be validated then it will be extended to 
predict the binding kinetics of CD16 to IgG and influence of different anchoring 
mechanisms employed by the receptor will be determined. 
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Explore The Differences In Solid Phase Kinetic Rates Of CD16 To Predict The 
Effect Of Anchoring Mechanism On These Extracellular Properties. 
CD16 is one of only four eukaryotic receptors known to natively exist in both the 
transmembrane (TM, CD16a) and the glycosyl phosphatidylinositol (GPI, CD16b) 
isoforms. The biological significance of this anchor isoform coexistence is not clear. Here 
we report that kinetic rates vary with CD16 membrane isoforms with the differences 




Agglutination Of Red Blood Cells
The forces that govern the cellular adhesion may be classified as nonspecific and 
specific.  The nonspecific forces, colloidal forces, have been extensively studied by 
physicists. These forces include electrostatic, van der Waals, depletion, and hydration 
forces. In biology, an example of specific adhesion is the process of agglutination which 
describes the antibody mediated clumping of particles expressing a certain specific 
antigen. The clumping of red blood cells occurs because the antibody binds to the 
specific antigens presented on the membrane surface. The process of agglutination is 
chemical reaction that can be expressed in two steps. Step 1 involves the attachment of 
antibody to a cell surface. This is a solution based process (or 3 dimensional, 3D) because 
the unattached antibody is in solution before it attaches to the membrane bound antigen. 
The next step involves the solid phase process (or 2 dimensional, 2D) of binding both the 
membrane bound antibody (or receptor) with the membrane bound antigen (or ligand). 
Various factors affect both steps and can be manipulated to increase or decrease the rates 
of reaction. 
Before agglutination can occur, the respective components must come together 
and form a suitable special relationship. As shown in Figure 2.1, the receptor and ligand 
must complement each other both structurally (stericly) and chemically. Forces that hold 
the receptor / ligand complex together are weak compared to a covalent bond and the 
complex is reversible, i.e., bonds are randomly forming and disassociating even after a 
state of equilibrium is achieved.
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Figure 2.1: Receptor-Ligand goodness of fit. a) good structural fit with complimentary 
charge attraction, b) chemical groups are complementary but the structural fit is poor, c) 
good structural fit but the charge groupings are not attractive and may repel one another.
Mathematical models describing the phenomena of agglutination are usually 
derived as a combination of chemical kinetic and thermodynamic models. When receptor 
and ligand are brought into close proximity, the opportunity for bond formation between 
them (cell adhesion) is created. First, diffusion of the receptor and ligand must occur until 
both are within the range of interaction. Next, the receptor and ligand react to form a 
















where: X= receptor density
Y= ligand density
XY= receptor/ligand encounter complex
Z= bond density
d+,-= rates of formation and dissolution of the complex
r+,-= forward and reverse rate constants for bond 
formation
Under most occasions, the concentration of encounter complex is small and the condition 
[ ] dtXYd is satisfied, Bell (1978). The individual rates of complex and bond formation 
a b c
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may then be combined into a single rate constant (then the overall affinity constant 
becomes  Ka=k+ / k-)
The binding of specific receptors and ligands is the result of random collisions 
between the two that create binding opportunities. The physicochemical characteristics of 
simple receptor-ligand bonding are deterministically described by equation 2-1 assuming 
that there is one determinant per molecule (i.e. monomeric binding). When at least one of 
the molecules is in solution, the diffusional portion of the equation accounting for the 
formation of an encounter complex is so rapid that it is usually dropped from the relation. 
For a given concentration of receptor, the amount of complex formed will depend on the 
concentration of ligand and the strength of the binding interaction which is characterized 
by the reaction rate. Different parameters are known to affect the rate of binding 
interaction. The strength of the interaction is an intrinsic property of the receptor-ligand 















 slope = - 1 / Kd
Figure 2.2: An example Scatchard plot.
At equilibrium the reaction can be characterized by the dissociation constant (Kd).  
The smaller the Kd, the greater the strength of molecular interaction and more complex is 
formed. The determination of binding affinity when one of the molecules is membrane 
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bound is commonly measured using a Scatchard method. With this protocol, the free 
molecule is labeled with a quantifiable agent, usually 125I. Cells expressing the receptor 
of interest are introduced to solute containing the labeled ligand and complex is formed 
on the cell surface. At equilibrium, the cells are isolated from the solute via 
centrifugation. The amount of quantifiable ligand on the cell surface is taken as the 
amount of complex formed and by titrating the concentration of free ligand in solution, a 
curve of complex versus complex / free ligand can be produced. For a bimolecular 
interaction, the slope of the linear fit of the data points is the negative reciprocal of the 
dissociation constant of the reaction as illustrated in Figure 2.2. Unfortunately, as the 
dissociation constant becomes large, the slope of the Scatchard plot approaches zero and 
an accurate determination of the reaction’s binding affinity is difficult. Under this 
condition, an alternative protocol is usually utilized called competition binding. The 
protocols for competition binding are much less standardized than those of Scatchard 
analysis because the reaction is more complex. The particular form of competition 
binding utilized in this work is described in detail in the Materials And Methods section.
Macroscopic Models Of Cell Adhesion
The receptor-ligand properties that are significant in determining the strength of 
adhesion between two cells are the molecular density, the individual rate constants, the 
lateral mobility, and the mode of separation between a receptor and its ligand. The 
importance of these properties is easily rationalized by examination of the theoretical 
models of cell adhesion. Simple early models (Bell, (1979), Bell et al., (1984), Dembo et 
al., (1988), Dembo, (1994)) also predicted that cell adhesion strength is directly related to 
the number of bonds formed and in turn a function of receptor and ligand densities on the 
cell membranes. Accordingly, Evans (1985) proposed that adhesion strength is a direct 
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function of the force required to break a single bond:
Z Z Z T
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where: NZ is the bond density, 
fZ is the force required to break a single bond, 
lZ is the extent of stretch required to reach peak force, 
FT is the total force to complete cell separation, and 
Ac is the contact area.
From equation (2-2), the greater the required force to break a single bond, the 
greater the total force to separate bound cells. Bell (1978) calculated the force to rapidly 
break a single CD16 - IgG type bond in the order of 1.2 pN per bond. Interestingly, the 
force calculated to uproot a receptor that is not anchored to the cytoskeleton was 
estimated at 1.0 pN per molecule which is the same order of magnitude.
The thermodynamic equilibrium model also serves to theoretically quantify which 
and how specific receptor properties effect adhesion strength. The thermodynamic model 
predicts the reversible adhesion energy density is dependent upon the natural logarithm of 















where: kB is Boltzmann’s constant, 
γ is the adhesion density (a measure of adhesion strength), 
θ is the absolute temperature, 
N is the number of receptors (X) or ligands (Y), and 
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KD is the dissociation constant (1/Ka). 
From equation 2-3, with a smaller the disassociation constant, a greater adhesion density 
can be expected. Bell (1978) predicted that the force to rapidly break a single bond could 







where: ro is the minimum interaction range (nm), 
fZ is the force to break a single bond (pN per bond), and 
EO is the free energy change on binding (eV). 
For a typical CD16 - IgG bond, letting Eo ~ 0.37 eV ( Ks ~ 106 M-1) and ro ~ 1 nm, results 
in a force, fZ, of 1.2 pN per bond. For a covalent bond a similar approach results in a 
force of 30 pN per bond. The force to uproot a receptor that is not anchored to the 
cytoskeleton is estimated at 1 pN per molecule. It is of interest to note again that the 
theoretical force to uproot a receptor and that to rapidly break a single bond are on the 
same order of magnitude.
Small Scale Probability Based Theories Of Cell Adhesion
Despite the obvious importance of kinetic rate constants to our understanding of 
various cell adhesion processes, not until recently have they been directly determinable 
experimentally. Although there are many methods of measuring receptor-ligand binding 
kinetics when at least one of the molecular species is in solution (i.e., three-dimensional
kinetics or solution phase), none of these methods can be applied when the two molecules
are bound to two apposed surfaces, as in the case of solid phase adhesion (i.e., two-
dimensional kinetics or solid phase kinetics).
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This inapplicability of these methods is due to the fact that they all require 
quantification of the concentration changes of the bound and free ligands with time. 
However, in cell adhesion assays one usually measures only the fraction of adherent or 
detached cells. Although there is no adhesive bond associated with a detached cell, the 
number of bonds on an adherent cell can vary from one up. The only published method 
for measuring the bond density using fluorescent labeling requires a 30-min incubation to 
allow lateral diffusion of the unbound molecules inside and outside of the contact area to 
reach the steady state, which is far longer than the kinetic transient time of many 
receptor-ligand interactions, including the ones studied in the present work. Therefore, 
only 2D binding affinity, not kinetic rates, can be measured by the method of Dustin et al. 
(1996). To the best of our knowledge, no other published method exists that allows direct 
measurement of the changes in the density of bonds with time when the receptor-ligand 
bonds are localized inside the contact area spanning a narrow gap between two cells or 
between a cell and a substrate surface.
Because of the inability to directly measure the time course of bond density, the 
kinetics of receptor-ligand binding has to be inferred from the changes in the fraction of 
adherent cells with time and its relation to the distribution of bonds among these cells. 
Kaplanski et al. (1993) were the first to employ this idea to measure adhesion kinetics. 
Previously, most of the published work on adhesion kinetics measurements used flow 
techniques. In the flow chamber, the kinetic rates were estimated by analyzing the 
probabilities of forming a durable adhesion per unit length of travel between a cell and 
the surface and of the duration of these adhesions. A problem inherent to the flow 
chamber method is the lack of ability to control the adhesion event. It is difficult to 
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determine (let alone control) from a top view observation whether a moving cell is in 
transient contact (i.e., colliding) with the surface until it is arrested. Therefore, the 
measured adhesion probability per unit displacement is a lumped parameter. It depends 
not only on the fraction of contacts that yield adhesion (adhesion probability per contact), 
but also on the number of contacts per unit length of travel (collision frequency), as well 
as on the duration and area of each contact. None of these can be measured separately and 
independently in the flow chamber system. Moreover, the formation of the first bond 
(which requires capture of the rapidly moving cell from the flow) is very different from 
that of the subsequent bonds (which involves receptor-ligand binding between two 
surfaces with much less relative motion). In addition, the size of the contact area, the 
duration of the contact, and the force exerted on the contact cannot be controlled by the 
experimenter, and they are all variable rather than constant in the flow chamber system. 
These make the estimate of the forward rate constant from the measured adhesion 
probability per unit distance difficult. Determination of the reverse rate constant, in 
contrast, is much simpler, because it involves only measurements of the lifetime of 
durable adhesions.
Evans et. Al. (1991) introduced the idea of studying small scale adhesion using 
the micropipette system. In his experimental system, the process of bond assembly led to 
the formation of only a small number of discrete attachments as he controlled the density 
of the agglutinin (which he did not quantitate) and the contact area. He proposed, as 
others had before, that even for a single bond the probability of survival attenuates with 
the duration of the load and that bond survival time decreases as the load increases. In his 
work the failure of even one bond was treated as a continuous stochastic process 
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dependent on the magnitude and duration of the applied separation force. The 
dissociation rate of the bond was proposed to be strongly dependent upon the mechanical 
force imposed on the bond. This was first proposed by Bell (1978) in the form:
( )TCa kFkk BTOrr exp= (2-5)
where kr = the reverse rate constant and 
the “o” superscript references the solution based 
determination, 
a = the molecular range of interaction, 
FT = the total force exerted on the bonds, 
kB = the Boltzman constant, 
T = temperature and 
C = the number of receptor/ligand complexes.
While Evans ideas were not new, the concept of applying these adhesion principles to a 
small number of bonds or even a single bond using the micropipette system was fresh. 
The concept that the kinetics of a small number of bonds would obey Poisson statistics 
was also reiterated from Bell.
Pierres (1996) explored the concept of the determination of a lower limit to the 
rate of association between antibody coated spheres and antigen coated surfaces in a flow 
chamber environment. The lower limit for the association rate was speculated to be the 
contact duration time between the coated sphere and the antigen coated surface. This 
limit was in the order of 0.001 seconds. This work was an experimental continuation of 
the work of Cozens-Roberts et al. (1990).
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Commercial Application Of Antibody Mediated Red Cell Adhesion
An application to any theoretical work is always desirable. The following 
describes a commercial test that utilizes red cell binding mediated by antibody-antigen 
binding. In fact, the purpose of the test is to determine whether specific antibody-antigen 
binding is present. In solid-phase indirect microplate techniques, a red cell coating across 
the bottom of a reaction well is created. The test serum containing possible anti-RBC IgG 
antibodies is added to the wells and allowed to react with the red cell monolayer. After 
which the wells are washed free of the unbound proteins (unbound antibody). The 
indicator for attached antibody is a centrifuged suspension of anti-IgG-coated red cells.
The reaction is positive if the indicator cells adhere across the sides of the well, Figure 
2.3. If they settle to the bottom, it demonstrates that no antigen-antibody reaction has 
occurred. This system represents a commercial product which depends heavily on solid 
phase IgG mediated red cell to red cell adhesion. The model of cellular adhesion 
presented in this work is applicable to this commercial test system with slight 
modification. This will be addressed in the recommendations for future work section.
13
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Reaction Grades Well Photographs Procedure
Grade 4
Step 1: The solid phase antibody 
detection system described is 
based upon an antigen 
opsonized 96 well plate.
Grade 3
Step 2: A test sample is added to the 
well along with a binding 
potentiator. 
Grade 2
Step 3: After an incubation period, the 
sample is washed from the 
well.
Grade 1
Step 4: An indicator cell sensitized 
with an anti-IgG antibody is 
added to the well and 
centrifuged.
Grade 0
Step 5: The indicator cell reaction is 
graded according the scale to 
the left.
Figure 2.3: The solid phase indirect antibody detection test is comprised of red blood 
cells which selectively express a desired antigen and are dried to the bottom of wells. 
Addition of a test sample allows for the formation of an antibody-antigen bond. After 
washing, adhered antibody is detected by the addition of anti-IgG coated red blood cells. 
These red cells are centrifuged to create a reaction pattern. (a) The possible reaction 
grades following centrifugation, ranging form strong positive to negative. (b) The solid 




Isotypes of antibody are distinguished by certain effector functions and structural 
features including a unique heavy chain isotype.  In man, the classes of antibodies are 
called IgA(α), IgD(δ), IgE(ε), IgG(γ), and IgM(µ).  In some species, the immunoglobulin 
classes are further differentiated according to subclasses, adding another layer of 
complexity to antibody structure.  In humans, for example, IgG antibodies comprise four 
IgG subclasses -- IgG1, IgG2, IgG3, and IgG4.  A schematic of IgG structure is shown in 
Figure 2-4. 
Figure 2.4: (a) The general structure of the four subclasses of human IgG.  (b) The 
residues which differ between IgG1 and IgG3 are indicated in yellow (c) Schematic 




Heavy chains (H) of all IgG isotypes are associated with light (L) chains of two 
isotypes -- κ and λ.  Thus, the basic H2L2 composition of an antibody can be specified in 
terms of its H and L isotypes; e.g., ε2κ2, (µ2λ2)5, etc. The adhesion assays described here 
take advantage of the versatility afforded by using IgG.  Purified IgG in many subtypes 
and species is inexpensive and readily available.
IgG activates and fixes complement, opsonizes bacteria, and mediates Antibody-
Dependent Cellular Cytoxicity (ADCC). It is actively transported across the placenta and it 
a secondary response (3-5 days)
IgM Structure
Plasma IgM circulates as a pentamer comprised of five heavy chains---light chain 
pairs. The pentamer is held together by disulfide bonds, and at the center of the molecule is 
a single peptide called the J chain, which induces the joining of the monomers into the 
pentamer. The J chain is synthesized by the B lymphocyte (or plasma cell) that makes the 
IgM.
IgM activates and fixes complement and is the most efficient immunoglobulin at 
activating complement via the classic pathway. It is an antigen receptor for the B cell and a 
primary response (7-10 days) antibody.
FcγIII Receptors
The structural segments of cell surface receptors consist of distinct domains as 
follows: a glycosylated extracellular domain linked to either a transmembrane (TM) 
domain with a cytoplasmic tail or to a glycosylphosphatidylinositol (GPI) moiety without 
TM and cytoplasmic domains. The anchor can influence the function of a receptor. TM 
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anchors of some receptors carry information for protein internalization and subunit 
association, whereas those of other receptors transduce signals. The GPI moiety consists 
of a glycan core sandwiched between ethanolamine and a lipid tail. Ethanolamine is 
covalently attached to the carboxyl terminus of the protein by an amide bond, whereas the 
lipid tail directly inserts into the outer leaflet of the membrane but does not cross the 
bilayer. The GPI anchor has been implicated in facilitating the lateral mobility of the 
protein on the cell surface and enhancing receptor-mediated cell adhesion.
There are four known eukaryotic receptors that naturally exist in both membrane 
anchor isoforms: neural cell adhesion molecule, lymphocyte function-associated antigen 
3, vascular cell adhesion molecule 1, and Fcγ receptor III (FcγRIII or CD16). Neural cell 
adhesion molecule mediates Ca2+-independent homophilic adhesion during the 
development of neurons with the GPI-anchored isoform being expressed later in 
development than the TM-anchored isoform. Lymphocyte function-associated antigen 3 is 
expressed on human erythrocytes as a GPI-anchored protein but on all nucleated cells as 
both membrane anchor isoforms. Vascular cell adhesion molecule 1 has been found with
both anchors in murine but not in human cells. The TM- anchored FcγRIIIa (CD16a) is 
expressed on macrophages, natural killer (NK) cells, and subsets of monocytes and T 
cells. The GPI-anchored FcγRIIIb (CD16b) is only expressed on neutrophils. The
physiological significance of this coexistence of two distinct membrane anchor isoforms 
for the same receptor is not clear.
CD16 is a 50-80-kDa highly glycosylated cell surface receptor for monomeric 
IgG. CD16b is polymorphic with the two alleles being termed neutrophil alloantigen 1 
(NA1) and 2 (NA2). CD16a and CD16b are products of two highly homologous genes, 
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and their 191 amino acid extracellular domains differ by only 6 amino acids (Figure. 2.5). 
CD16b lacks the 20-amino acid TM segment as well as the 25-amino acid cytoplasmic
domain of CD16a. In addition, the surface expression of CD16a requires associated 
subunits, the γ chain of the Fc receptor or the ζ chain of the T cell receptor, which form a 
homo- (γ -γ or ζ- ζ) or hereto (γ -ζ)-dimer in complex with CD16a (Figure 2.5). Binding 
of antigen-constrained IgGs brings about cross-linking of CD16, which can trigger a 
variety of immune functions, including immune complex clearance, phagocytosis, 
antibody-dependent cellular cytotoxicity, release of inflammatory mediators, and 
enhancement of antigen presentation.
Ligand binding of CD16 can be influenced by a number of factors. CD16a on NK 
cells binds monomeric human IgG (hIgG) with higher affinity than CD16b on 
neutrophils. It is not known, however, to what degree this differing affinity is due to the 
differences in the extracellular domain, in the membrane anchor, or in the cellular 
background of the two membrane isoforms. The two alleles of CD16b, which differ by 
four amino acids and two glycosylation sites in the ectodomain (Figure 2.5), have the 
same affinity for hIgG1 complex but different affinities for hIgG3 complex. NK cell 
CD16a has a higher affinity for hIgG than monocyte CD16a despite the fact that the two 
proteins have an identical polypeptide core, suggesting that glycosylation can influence 
CD16a's affinity for the ligand. Miller et al. reported higher affinity for murine IgG2a 
(mIgG2a) of CD16a than of CD16a-GPI, a molecule created by replacing the TM and 
cytoplasmic domains of CD16a with a GPI anchor. These authors suggested an affinity-
enhancing role for the associated γ chain of CD16a. The second specific goal of this thesis 
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is to determine whether the binding differences observed between the different CD16 
isoforms are a result of the different anchor mechanisms.
Figure 2.5: Schematic of receptor and CD16 isoforms. (a) two CD16a membrane anchor 
isoforms. (b) two CD16b alleles. (c) two CD16a-subunit chimeras. The extracellular 
domains, which begin at amino acid 18, are depicted as two Ig-like globules with the 
glycosylation sites shown as sticks. The amino acids in the ectodomain that differ among 
the various molecules are listed. Comparing to those in CD16a, the different amino acids 
in CD16b are underlined, and the differences between the two CD16b alleles are shown in 
italics. The lost glycosylation site in CD16bNA1 due to the change Ser-65  Asn-65 is 
indicated by *, whereas the gained glycosylation site in CD16bNA2 due to the change 
Asp-82  Asn-82 is indicated by +*. The CD16a-TM and the two CD16a-subunit 
chimeras differ by the TM and cytoplasmic domains but have the same ectodomain and 
anchor to the cell surface via the same TM mechanism. By comparison, the CD16a-GPI 
and the two CD16b alleles use a lipid tail to insert into the outer leaflet of the bilayer but 
do not cross the membrane. The GPI moiety is of similar size to an Ig globule. Hence it 
may extend the membrane-proximal ligand-binding Ig domain further above the 







The cDNAs encoding human CD16A-TM in a pSVL vector and CD16a-GPI in a 
pCDM8 vector were provided by Dr. J. Ravetch (Sloan-Kettering Institute for Cancer 
Research, New York). The CD16a-TM cDNA was further subcloned into the PCR3uni 
vector (Invitrogen, San Diego, CA), see reference. The cDNAs encoding the two human 
CD16b alleles, the γ subunit of rat Fc RI, the two chimeric CD16a-γ and CD16b-ζ, and 
the hygromycin or neomycin resistance genes have been described (Nagarjan et al. 
(1995)).
Cells And Antibodies
Our CHO cells transfected to express human CD16a have previously been 
described (Nagarjan et al., 1995). The control CHO cells (untransfected, K1 and 
transfected to express αIIbβ3, A5) were generous gifts from Dr. Mark H. Ginsberg 
(Scripps Research Institute, La Jolla, CA). CHO cells were cultured in Roswell Park 
Memorial Institute (RPMI) 1640 media (Sigma, St. Louis, MO) supplemented with 2 mM 
L-glutamine (Sigma), and 10% fetal bovine serum (FBS) (Gibco BRL, Grand Island, 
NY). For the CD16a transfectants, 400 µg/ml geneticin (Life Technologies, Gaithersburg, 
MD) was included in the culture media as a selection antibiotic to suppress the
nontransfected cells. The expression of CD16a was periodically checked via flow 
cytometry. Because the micropipette is a single-cell assay and cell-to-cell variations 
contribute significantly to experimental deviation, a homogeneous cell population 
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expressing a uniform level of CD16a is desirable. To obtain homogeneous populations of 
cells expressing different receptor densities, CHO cells were sorted through a FACSort 
(Becton Dickinson, San Jose, CA). The tight receptor expression distributions in the 
sorted populations lasted ~1 month before the cells returned to their original, more
heterogeneous characteristics.
Observing approved NIH guidelines, fresh blood from healthy donors was 
collected by venipuncture into sterile vacutainers (Becton Dickinson) with EDTA as an 
anticoagulant. Tubes were refrigerated for 4 h to allow serum separation. The RBC 
fraction was collected, washed twice in RPMI 1640 with 5% FBS, and then stored at 5°C.
These cells could be used for up to ~2 weeks, after which lysis of the RBCs became 
apparent.
Total human IgG (hIgG) (Lampire, Pipersville, PA) and rabbit IgG (RbIgG) 
(Sigma) were used as ligands for CD16a. The fluorescein isothiocyanate (FITC)-coupled 
goat polyclonal anti-human, anti-rabbit, and anti-mouse antibodies used in flow 
cytometry were purchased from Sigma. The monoclonal antibody (mAb) Leu-11b (mouse 
IgM) specifically directed against CD16 was purchased from Becton Dickinson. Another 
anti-CD16 mAb Fcgran1 CLB (mouse IgG2a) and the irrelevant control mAb X63 
(mouse IgG1) were produced in house as previously described (Nagarjan et al., 1995). 
The fragmentation of CLB into Fc and Fab subunits was done by Lampire. The 
genetically engineered dimeric soluble form of CD16a (sCD16a) and the control soluble
molecule B7 (sB7) were produced by our laboratory and will be described in detail 
elsewhere (Li et al. (2000)).
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Coating Of Ligands
Ligand was coated onto RBCs by a standard chromium chloride (CrCl3) coupling 
protocol (Gold and Fudenberg, 1967; Kofler and Wilk, 1977). Briefly, 108 RBCs were 
suspended in 250 µl saline (4% hematocrit). When ligand (hIgG, RbIgG, or a control 
protein bovine serum albumen (BSA); Sigma) in phosphate-free medium (typically at 10 
µg/ml) was added along with 250 µl of 0.001% CrCl3 solution in 0.02 M acetate buffer,
pH 5.5, spontaneous coupling occurred. After 5 min the reaction was quenched with 
phosphate-buffered saline (PBS), 5 mM EDTA with 1% BSA. RBCs were used 
immediately after protein coating. This coupling reaction is accomplished almost 
immediately and is thought to involve the chemical bonding of protein carboxyl groups 
with membrane proteins on the RBC. The reaction is nonspecific, the orientation of the 
coated protein with respect to the membrane is most likely random, and the ligand density 
has to be determined for each reaction to circumvent variability in the coating. 
Nevertheless, the method is extremely efficient in terms of time, coating densities, and 
minimum alteration of RBC membrane characteristics.
Determination Of Receptor And Ligand Densities
The surface densities of receptors and ligands were determined primarily via flow 
cytometry analysis. Samples of RBCs used in the micropipette experiment were 
incubated with FITC-labeled goat anti -human or anti-rabbit antibodies, depending on the 
origin of the coated IgG ligands. For negative controls, the hIgG (or RbIgG)-coated RBCs 
were incubated with the FITC-labeled goat anti-rabbit (or anti-human) antibodies. CHO 
cell samples were first preincubated with the mouse anti-CD16 mAb Fcgran1 CLB (or 
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without a primary antibody for control) and then with a FITC-labeled goat anti-mouse
polyclonal secondary antibody. The fluorescent intensities of the cells were compared to 
standard calibration beads (Flow Cytometry Standards Corp., San Juan, PR) to determine 
the mean number of events per particle, which was directly converted into labeled protein 
per cell with manufacturer-provided software.
Receptor densities on different CHO cell populations were cross-checked by 
radioimmunoassay. Fab fragments of CLB were iodinated using Iodo-Gen (Pierce, 
Rockford, IL) (Selvaraj et al., 1988). CHO cells were incubated in titrated concentrations 
of CLB-Fab, and the bound fraction was determined with a gamma counter. Scatchard
analysis (Scatchard, 1949) was employed to derive the (3D) affinity (of CD16a-CLB 
binding) and the (average) receptor number per cell, which was then divided by the 
apparent area of the spherical cell to convert to surface density. Determination of receptor 
density by Scatchard analysis was less desirable than that of flow cytometry because it 
required the constant availability of 125I-CLBFcgran-1 (Fab fragment); however, the 
correlation between the two methods is good (R2 ~90%) (Chesla et al. (1998)) and 
imparts more confidence on our surface protein density estimations. Radiolabeling of 
proteins was done by using IODO-GEN-coated tubes (Pierce) (Nagarajan et al. (1995)).
Three-Dimensional Binding Studies
The binding affinities of CLBFcgran-1 Fab for the two CD16a membrane anchor 
isoforms were determined by Scatchard analysis (Scatchard (1949)). The low affinity of 
monomeric IgG for CD16 makes direct measurement by the Scatchard method unreliable. 
To circumvent this difficulty, a competitive inhibition assay was used where the low 
affinity ligand IgG competes with the high affinity antibody CLBFcgran-1 for receptor 
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binding (Horovitz et al. (1987)). Briefly, CHO cells were grown in flasks until near 
confluence. Cells were rinsed once in PBS and then removed from the flask using 
PBS/EDTA (containing 5 mM EDTA). After washing, they were resuspended at 1 × 106
cells/ml in PBS/EDTA, pH 7.5. Cells were then added to V-bottom 96-well plates at 100 
µl per well. The wells were precoated with 1% IgG-free BSA (Sigma) in PBS by 
incubating at room temperature for 2 h. They were rinsed with PBS/EDTA and kept on 
ice until the cells were added. After adding cells, the plates were spun at 2000 rpm for 
2 min. The supernatant was removed, and a solution of 50 µl of PBS/EDTA and titrated 
amounts of IgG was added to each well with mixing. Then, 50 µl of PBS/EDTA, 0.25-
0.50 µg/ml 125I-CLBFcgran-1 Fab was added to each well, followed by a 45-min
incubation on a shaker at 5°C. After washing 3 times, the cell pellets were removed and 
counted in a gamma counter.
In the presence of increasing concentrations of the low affinity ligand (IgG, 
concentration cll), the binding of the high affinity ligand (125I-CLBFcgran-1 Fab, 
concentration clh) to the cell surface receptor (CD16) is gradually reduced or displaced. 
The displaced fraction (F), defined as the bound fraction (f) of CLBFcgran-1 normalized 


























































Since the affinity to CD16 of 125I-CLBFcgran-1 Fab (Kah) and the receptor 
concentration (cr) were predetermined from a separate experiment by Scatchard analysis, 
the only unknown in Equation 3-1 is the affinity of IgG (Kal). Therefore, Kal can be 
calculated from a single measurement of F without the experimental displacement curve 
to include data at the IC50 point. To increase the accuracy of the Kal value, however, the 
predicted displaced fraction (Equation 3-1) was nonlinearly fit to the entire F versus cll
data set.
The Micropipette System
The micropipette system used in this laboratory was designed, built, and 
calibrated in house; the majority of the components were purchased off the shelf 
(Delobel, 1992). It is similar to those established in other laboratories (Paul Sung, 
University of California at San Diego; Evan Evans, University of British Columbia; 
Robert Hochmuth, Duke University). The system consists of video-enhanced optical 
microscopy, micromanipulation, and pressure regulation subsystems.
The centerpiece of the microscopic system is a Zeiss inverted microscope 
(Axiovert 100; Oberkochan, Germany) with a 100× oil immersion, 1.25 N.A. objective. 
Diffraction is minimized with a green light (546-nm wavelength) band-pass (5-nm 
bandwidth) filter that also reduces any photochemical damage to the RBC. Additional
magnification is obtained using a 5× relay lens, leading to a charge-coupled device 
(CCD) camera (model 72S; Dage-MTI, Michigan City, IN). A digital image processor 
(model DSP-2000; Dage-MTI) is used to enhance the image. The signal also passes 
through a digital voltage multiplexer (model 401; Vista Electronics, Ramona, CA), which 
allows video integration and display of a timer on screen. Recording is accomplished 
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using a super VHS video cassette recorder (model AG-7355; Panasonic, Secaucus, NJ). A 
video monitor (Panasonic) displays the image at a final magnification of ~2500× as 
calibrated by a stage micrometer.
Micropipettes are made from borosilicate glass tubing (Richland Glass, Richland, 
NJ) with an outside diameter of 1 mm and an inside diameter of 0.7 mm. To guarantee 
clean pipettes, the original glass tubing is cleaned with acetone, cleaned a second time in 
a boiling solution of 50% ethanol for 1 h, and dried again. A two-step process is used 
with the first, utilizing a micropipette puller (model 700D; Kopf, Tujunga, CA). Next, a 
microforge (built in house, similar to commercial models, except that a glass bead is 
added to the filament, adapted from the laboratory of Robert M. Hochmuth, Duke 
University, Durham, NC) is used to break the micropipette with a flush tip at the desired 
diameter. The pipettes are connected to the pressure regulation system through stainless
steel injection holders. Each pipette can be coarsely manipulated by a mechanical drive 
mounted on the microscope and finely positioned with a three-axis hydraulic 
micromanipulator (Narishige, Tokyo, Japan). In addition, one of the pipette holders is 
mounted on a piezo translator (Physik Instrumente, Waldbronne, Germany), the driver of 
which is controlled by a computer to achieve precise and repeatable movement of the 
pipette in an adhesion test cycle. To avoid vibration of the micropipettes during the 
experiment, the microscope, along with the micromanipulators, is seated on an air 
suspension table (Kinetics Systems, Boston, MA).
The pressure regulation subsystem is used to control suction during the 
experiment and is critical for tuning the sensitivity of the RBC picoforce transducer. A 
hydraulic line connects themicropipette holder to a fluid reservoir. The centerpiece of the
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design is a fine jack that allows the height of the reservoir to be precisely manipulated. A 
metric long-range dial indicator (Starrett, Athol, MA) was attached to the reservoir to 
measure its position and therefore the applied vacuum pressure in mm H2O.
Micropipette Adhesion Test Cycle
CHO cells were removed from flasks with 5 mM EDTA/PBS, washed twice in 
RPMI, and then stored on ice until injection into the micropipette chamber. The chamber 
consists of two coverslips attached to a stainless steel holder on the top and bottom to 
allow optical imaging, while open on two sides to allow micropipette access. The solution 
used in the chamber during the experiment was half isotonic (1:1 distilled H2O and 
Hanks' balanced salt solution (HBSS) without Ca+2 (Sigma) and 1% BSA), which caused 
the RBCs to swell to nearly spherical shape, but had no detectable effect on the CHO 
cells' viability, consistent with the report of a recent paper (Setiadi et al., 1998) that CHO 
cells have a high tolerance to variations in the ionic strength in the culture medium. After 
single CHO and RBC cells were captured and positioned with the apposing pipettes, the 
computer program for repeated adhesion test cycles was initiated, with the movement of 
the RBCs precisely driven by the piezo translator and the CHO cell held stationary (Fig. 
3.1).
An adhesion test cycle consists of impinging the RBC into controlled contact 
(Fig. 3.1a), allowing the contact to continue for a predetermined incubation time, then 
retracting the RBC from the CHO cell at a predetermined rate and observing any 
adhesions. The contact area is managed by controlling the amount of RBC impingement
on the CHO cell surface. Because the piezo-controlled RBC returns to the same location 
after every adhesion stroke attempt, impingement is controlled by manual adjustment of 
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Figure 3.1: Photomicrographs of a typical adhesion test involving an IgG-coated RBC 
aspirated by a micropipette (left) and a CD16a-expressing CHO cell, aspirated by another 
micropipette (only partially shown, right). (a) The RBC was brought into contact with the 
CHO cell with an overall apparent contact diameter of ~2 µm. The contact area and time 
between the CHO and RBC cells were carefully controlled. (b) The unaspirated portion 
of the RBC is shown in its free, spherical shape. (c) A retracting RBC that was previously 
allowed to adhere to a CHO cell. The attachment site between the two cells appears as a 
single point in the microscopic image. (d) The retracting RBC adheres to the CBO cell to 
the CHO cell via two spatially distinctly separate point attachments.
Adhesions could easily be unambiguously distinguished from nonadhesions (Fig. 
3.1b) by deflections in the RBC surface at the area of contact (Fig. 3.1c and d). Most 
observed adhesions were point attachments near the apex of the RBC (Fig. 3.1c). 
Multiple point attachments were also occasionally detected (Fig. 3.1d), especially at 
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higher adhesion frequencies. The outcome of each test was scored as one if adhesion 
resulted, and as zero if not.
The adhesion test cycle was then repeated at the same contact area. Typically a 
sequence of 50-200 such repeated tests was performed with the same pair of cells. The 
binary adhesion scores were averaged up to the most recent test, and this running 
frequency of adhesion was plotted against the test cycle count for a given sequential test 
series. It is the analysis of this running frequency that yields an estimate of the adhesion 
probability per contact.
Data Analysis
The theoretical solutions were fitted to the experimental data by a numerical 
routine that employs the Levenberg-Marquart method to evaluate the parameters that 
minimize the sum of squared weighted (by the reciprocal standard deviations) errors (χ2) 
between the data and the predictions (Press et al., 1989). The program also uses the 
spread and standard deviation of the data to estimate the standard deviations of the fitted 
parameters. To determine the most appropriate kinetic mechanism, the goodness of fit of 
various models as measured by the χ2 values for the same data set were compared (Piper 
et al., 1998).
Probabilistic And Deterministic Kinetic Models
The experiment of the present method is designed to operate in such a way that 
adhesion appears as a random event, i.e., whether or not binding occurs in a particular 
adhesion test is nondeterministic, even when all conditions controllable by the 
experimenter, including the area (Ac) and duration (t) of contact between the two cells, as 
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well as their respective surface densities of receptors (mr) and ligands (ml), are kept 
identical. It is hypothesized that such randomness is a manifestation of the stochastic 
nature inherent in the chemistry of receptor-ligand binding, which becomes significant
when the number of bonds per cell is small. A single deterministic value (scalar) for the 
(averaged) surface density of bonds, n /Ac, is no longer adequate for a complete 
description of the phenomenon, as the number of bonds that an adherent cell may have 
becomes a discrete, time-varying, random variable that fluctuates significantly. Instead, 
one considers a probability vector {p0, p1, ..., pn, ..., pAcmmin} to describe the state of the 
system. In other words, the adhesion could be mediated by any number of bonds ranging
from 0 to Acmmin, where mmin = min(mr, ml). Each possible scenario, say adherent via n
bonds, has a defined likelihood, given by pn . 
For the experiment in question, there is no bond at the instant when the two cells 












Upon contact, bonds start to form, so pn(t) (n > 0) increases with time t. For a single step 
reversible reaction of νr receptors (designated Mr) binding to νl ligands (designated Ml) to 
form νb bonds (designated Mb), as given by the chemical reaction equation








the master equations that govern the rates of change of these Acmmin + 1 probability 
components can be written as 
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where kf0 and kr0 are, respectively, the forward and reverse rate constants, of 
dimensions [area] νr+νl-1[time]-1 and [area] νb-1[time]-1, respectively. The superscript 0 is 
used to indicate that these are rate constants measured under the condition that there is no 
external force applied to the bonds.
The above probabilistic master equations are generalization of the deterministic 
kinetic equation, as can be seen in the following derivation. Multiplying Eq. 3-3 by n/Ac
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where  denotes averaging. n /Ac in Eq. 3-4a can readily be identified as corresponding 
to the deterministic density of bonds. The two measures of fluctuations in the bond 
number are 
σ n







νr – i(A cml)
νl – j(– ν rνb )
i(– ν lν b)




(ν b) ≡ <nνb> – <n>ν b (3-4 c) 
It can readily be shown that 
σ n
(ν b) = 0
 
when νb = 1, 
σ n
(ν r + ν l) = 0  when νr + νl = 1, 
σ n
(ν b) = σ n2 when νb = 2, and 
σ n
(ν r + ν l) = σ n2  when νr = νl = 1, 
where σ n2  is the variance of n. For large systems, the fluctuations are small. 
Dropping σ n
(ν r + ν l) and σ n
(νb )  from Eq. 3-4a reduces it to the familiar deterministic kinetic 
equation, as expected.
Closed-Form Transient And Steady-State Solutions
Two simplified versions of Eq. 3-3 have been discussed in the literature. The first 
case is when one of the molecular species excessively outnumbers the other. Under such a 
condition the number of the former species [density mmax = max(mr, ml)] in the free state 
can be approximated as constant in the contact area, as the reaction is limited by the 
availability of the latter species (density mmin). The vr = vl = vb = 1 case of such a 
simplified version of Eq. 3-3 was used by Cozens-Roberts et al. (1990) when they first 
applied the probabilistic kinetic formulation of McQuarrie (1963) to the analysis of 
receptor-ligand binding. The solution to the simplified version of Eq. 3-3 that satisfies the 






n 1 – p(t)
Acmmin – n (3-5a) 
where p(t) is the probability of forming one bond, given by 
p(t) =
1 – exp(– k t)
1 + (mmaxKa0)– 1
(3-5b) 
The two parameters, 
Ka0 = kf0/kr0 and 
k = mmaxkf0 + kr0, 
are the equilibrium association constant (binding affinity) and the overall rate 
(reciprocal time scale) of the reaction, respectively.
The second case is that in which the number of bonds that have nonvanishing 
probabilities is much smaller than the numbers of receptors and ligands. Under such a 
condition the formation of a small number of bonds will not significantly deplete the free 
receptors and ligands available in the contact area, so Eq. 3-3 can be approximated by 
one that neglects, respectively, n and (n-1) in the [Acmj  (νj/νb)n] and [Acmj   (νj/νb)(n -
1)] (subscript j = r or l) terms. Such simplified master equations (with variable kinetic 
rates) have been discussed by Long et al. The νb = 1 case (with constant kinetic rates) was 
employed by Kaplanski et al. (1993), who solved the equations numerically. (Different 
notations, k+ = Acmrνrmlνlkf0 and k  = kr0, were used by Kaplanski et al. (1993). The 
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where n  is the average number of bonds, given by 
<n> = Acmrνrml
ν lK a
0[1 – exp( – k r
0t)] (3-6b)
These results are not surprising, as the assumptions on which Eq. 3-3 is based are 
equivalent to those underlying the binomial and Poisson distributions. Both distributions 
have been suggested to describe the formation of a small number of bonds (Capo et al., 
(1982); Chesla et al., (1995); Evans and Ritchie, (1994)). However, in contrast to the 
previous works that assumed p and n  given a priori, closed-form solutions provide their 
explicit expressions, Eqs. 3-5b and 3-6b.
Although an explicit transient solution to Eq. 3-3 in the form similar to that of Eq. 
3-5 or 6 for arbitrary r, l, and b values has not been found, an implicit solution can be 
obtained by assuming {pn(t)} = {An}ert to convert the problem of solving Acmmin + 1 
coupled, first-order, constant coefficient, ordinary differential equations to one of finding 
the eigenvalues r and eigenvectors {An} of the corresponding linear algebraic system 
(Boyce and DiPrima, (1977)).
At steady state, explicit exact solutions for Eq. 3-3 have been obtained for 
arbitrary stoichiometric coefficients (Zhu et al., (1998)). These steady-state solutions,
derived by using mathematical induction (Piper, 1997), are, respectively:
34
pn(∞) =




















}– 1 n = 0
p0(∞)(n!)





























































(m!)ν bΣm = 0
∞










where νa = νr and 
νI = νl if  mmax = mr, but
νa = νl and νI = νr when mmax = ml. 
Note that as t  ∞ , Eqs. 3-5 and 3-6 approach, respectively, the νr = νl = νb = 1 
case of Eq. 3-8 and the νb = 1 case of Eq. 3-9, as expected.
These explicit exact steady-state solutions, Eqs. 3-7 through 3-9, are of interest 
because they greatly facilitate the test of the validity of the binomial and Poisson 
solutions, Eqs. 3-5 and 3-6. As one might expect from physical intuition, the 
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discrepancies between the binomial and Poisson approximate solutions and the solution to
the original master equations, Eq. 3-3, are at maximum at steady state because this is 
when the average bond number reaches maximum. Thus the discrepancies between the 
steady-state solutions, Eqs. 3-7 and 8 (or Eqs. 3-7 and 3-9), represent the worse-case 
scenario for all time-dependent solutions. The results of the validity test are shown in 
Figure 3.2, in which the p0(∞) ratio of the solution to the simplified version to the 
solution to the full master equations is plotted against either mmax/mmin (Fig. 3.2a) or (νb/
νi)Acmmin/ n (Fig. 3.2b). It can be seen that, when mmax/mmin [or (νb/ νi)Acmmin/ n ] is on 
the order of one, Eq. 3-8 (or 9) differs significantly from Eq. 3-7, suggesting the 
breakdown of the binomial (or Poisson) type of approximation. However, as mmax/mmin
[or (νb/ νi)Acmmin/ n ] increases to more than 50, the p0(∞) ratio quickly approaches
unity, supporting the validity of the solution to the simplified master equations in 
approximating the solution to the full equations in these parameter domains, which 
correspond to the conditions of the present experiment.
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Figure 3.2:  Validation of the two simplified master equations in approximating the full 
master equations. The ratios to the full steady-state solution (Eq. 3-7) of the binomial-
type steady-state solution (Eq. 3-8) (a), and the Poisson-type steady-state solution (Eq. 3-
9) (b) are plotted against the parameters mmax/mmin for the binomial-type solution and (νb/
νi)Acmmin/ <n> for the Poisson-type solution, respectively, that control the validity of the 
corresponding approximation. Different curves represent different stoichiometric 
coefficients (νb, νr, νl), as indicated. Note that the experimental conditions in the present 
work satisfy [(νb/ νi)Acmmin/ <n>] > 100, which is in the parameter range that validates 




Micropipette Force Determination Precision
The determination of detachment force can also be extracted from the CD16-IgG 
reactions observed using the micropipette system. In the determination of detachment 
force, an estimate of the micropipette systems precision was sought. A precision 
assessment first requires the determination of the force-deflection relationship, which 
requires a none trivial analysis of the mechanics of the RBC under a point load bond. In 
the mechanics literature a solution to a similar problem is available by Reissner (1946). 
However, the constitutive law used was that of 3-D isotropic elasticity. It is therefore not 
applicable to the RBC problem because the RBC membrane is known to behave as an
anisotropic material whose in-plane mechanical properties are much different from those 
in the third dimension. Evans analyzed the RBC transducer problem using a finite 
difference numerical approach and established the sensitivity of such a device. Here a
finite difference assessment of the precision of the RBC transducer is also presented so 
that the results obtained from this and other techniques can be fairly compared. 
Analytical solutions (via perturbation and linearization) to the membranes mechanics 
problem are also available in our lab and can be compared to the computational solution. 
Each of these mechanical solutions contains the components of membrane binding. In 
addition, the theoretical models are directly validated with independent experimental 
measurements. The solutions are then used to predict the precision of the force 
measurement devise, identify the most important concern areas of experimental accuracy, 
and the influence of binding and area dilution constants to the final solution. 
Mechanical characterization of cell membranes has been a biomedical area of 
research beginning in the early 20th century and continuing into the 1970’s with the 
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introduction of the Singer and Nicolson Fluid Mosiac Model. The experimental study of 
biological membranes has focused mainly on human red blood cells (RBCs) and 
characterizes their deflective characteristics under load with the use of several properties: 
elastic and bending moduli. If the membrane undergoes large deformation, the isotropic 
prestressed tension will no longer dominate. In order to determine the deformed shape of 
a human RBC membrane surface under applied loads, the stresses need to be related to 
the strain. A linear elastic assumption is commonly applied to the human RBC and two 
elastic moduli are defined, the modulus for area dilation, K, and the shear modulus, µ.. 
The total volume of the enclosed by the membrane is constant during the imposed 
deformation which is typically assumed axisymmetric about z. The 2-D curvilinear 
coordinate system describing the membrane deformation is presented in Figure 3.3; the 
shape of the membrane is defined by r = r(z) with s defined as the arc length and φ as the 
angle around the z axis. Because the problem is axisymmetric the stress resultants τs and 
τφ are the principle stresses and τφs=0 and ∂/∂φ = 0. Therefore, the membrane equilibrium 
equations are presented as, where m and φ are directions normal and tangential to the 
membrane surface, respectively:
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The geometries of a micropipette aspirated RBC before (dotted curve) and after 
(solid curve) the application of a point force on the apex is shown in Figure 3.3. This 
geometry also illustrates the nomenclature of the membrane equilibrium equations given 
in equations 3-10 and 3-11. 
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Figure 3.3: Geometries and coordinate system of a micropipette aspirated RBC under a 
point load at the apex.
Two principle stretch ratios are defined along the m and φ coordinate lines as λm
and λφ and T is the isotropic prestressed tension in the RBC membrane, see Equations 3-
12 and 3-13. The reference configuration is defined in a prestressed state rather than the 
stress-free state so that when the area dilation vanishes, the mean membrane tension is 
equal to the prestress tension rather than zero. The binding rigidity is defined as B and the 





Under the previous definitions, the following constitutive equations are used to relate the 
in-plane tensions and bending moments to the stretch ratios and curvatures:













Mm = M φ = B cm + cφ – 2Rc
– 1 (3-16)
In the finite difference analysis, the equations are discritized into segments along 
the membrane and the polar region is essentially treated as cone. The resolution of the 
apex cone section is controlled by increasing or decreasing the number of segments used 
in the analysis. The red cell was broken into inside and outside pipette sections. The 
outside section of the membrane was assumed symmetric about the maximum change in 
radius, Rc , as shown in Figure 3.4. Note that the z location of Rc is different in the loaded 
versus unloaded RBC. 
Figure 3.4: Geometries and coordinate system of the finite difference solution method to 
a micropipette aspirated RBC under a point load at the apex.
Two boundary conditions are imposed on the solution:
2
π=Ψ at   Rc max, (3-17)
0=Ψ at 0=Rc (3-18)
In addition, the solution imposed both area and volume conservations upon the 
geometry. The deformation of the red cell is converted into a finite difference problem by 
sectioning the red cell problem into a series of sections across the z axis and taking a 
Taylor series expansion of constitutive equation. The initial guess for the problem 
solution was the initial undeformed condition. Each solution imposed a force to the apex 
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of the red cell and solved the constitute equations to achieve equilibrium. From each of 
these solutions the spring constant of the red cell could then be back calculated. Because 
the size of the cone segment at the problem apex is critical to the solution and the shape 
at the apex is a function of the imposed force, the number of segments in the solution is 
dependent upon the imposed force. The overall solution is joined together as a function of 
each unique solution at each imposed force. As such there is an expected small 
nonlinearity when the solutions are joined as a result in the error tolerance at each 




This thesis completes two specific aims or goals. Two papers (Chesla et al. 1998 and 
2000) address these aims in detail; in both papers I was the lead author with extensive 
contributions. During the course of this research, I also explored other directions and 
gathered initial data. These directions were further explored by other researchers and are 
presented here and also appear in publications where I am a coauthor. Nagaragjan et al. 
1995, presents data confirming the ability of CHO cells to phagocytosis immune 
complexes on the single cell level via fluorescent microscopy. This is an important 
contribution to immunology as it presents a cellular model for the study of signal 
transduction via CD16 isoforms. Zhu et al. 2002 presents data supporting the 
measurement of single receptor/ligand bonds via micropipette. This is important because 
biophysical research has recently focused on the resolution of kinetic rates, lifetimes and 
rupture forces at the signal bond level. Huang et al. 2004 presents data that introduces the 
effect of receptor/ligand orientation and/or length on the measure kinetic rates. This is 
important because these parameters are often overlooked in biophysical analysis and their 
quantification here illustrates their significance in the determination of solid phase kinetic 
rates.
Quantification Of Receptor And Ligand S urface Densities
The quantification of surface densities of CD16a expressed on CHO cells and IgG 
coated on RBC is illustrated in Figure 4.1. Figure 4.1a shows the results of one of the 
radioimmunoassays (Scatchard plot) used to quantify the receptor density. Figure 4.1b
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shows the receptor expression in samples of the same CHO cells measured by flow 
cytometry with calibration beads. As can be seen in Figure 4.1c, the receptor densities 
determined via the two methods are comparable. Flow cytometric analysis was solely 
used to determine the ligand densities on RBCs (Figure 4.1d)
Figure 4.1: Quantification of molecular density on the cell surface. (a) The 
radioimmunoassay method involves radiolabeling specific antibodies and determining its 
density by counting the amount of antibody bound to the cell surface as it varies with the 
concentration of antibodies added in the solution. The x intercept of the Bound/Free 
versus Free line in the Scatchard plot predicts the total number of receptors per cell, (b) 
The flow cytometer method is similar, except that the cell labeling is accomplished in a 
two-step process with the fluorescent secondary antibody. The distributed fluorescent 
intensity of the CD16a+ cells (shaded curve) is then compared to those of the standard 
calibration beads (four unshaded curves, arrows). The negative control (without primary 
antibody) (unshaded curve near origin) is shown for comparison. (c) Comparison 
between receptor densities determined by the two methods, using sorted CHO cells 
expressing various narrow levels of CD16a (points). A strong correlation can be seen 






Measurement Of The A dhesion Probability
The measurement of adhesion probability per contact is illustrated in Figure 4.2, 
in which the running averages (adhesion frequency) of the binary adhesion scores (one if 
adhesion results, and zero if not) for sequential adhesion tests are plotted against the test 
cycle count. Not only was the same pair of cells used in each set of repeated tests, but the 
location, area, and duration of all of the contacts in the same sequence were also kept 
constant by the experimenter. Thus the fluctuations in the running frequencies, especially 
at low test cycle counts, were most likely due to the randomness inherent to small system 
kinetics of receptor-ligand binding. The running adhesion frequencies became stabilized 
as the test number increased, allowing the adhesion probability, Pa, to be estimated from 
the adhesion frequency (see Fig. 4.2 legend). To ensure statistically stable results, at least 
400 repeated tests were conducted for each data point, using multiple cell pairs. A total of 
~7250 single cell pair adhesion tests were performed to yield the data presented here
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Figure 4.2: Measurement of adhesion probability per contact. (a) The running averages 
of adhesion scores versus test cycle counts of three sequences of 200 adhesion tests 
each, each performed in a single cell pair of a CD16a-expressing CHO cell (mr = 650 
µm 2) interacting with a RBC coated with either human IgG (ml = 1200 µm 2, solid 
curves) or BSA (dashed curve). The apparent contact area was kept constant (~3 µm2) 
for all tests. The contact durations were t = 5 s for the BSA (nonspecific) and one of the 
hIgG-coated test series and t = 10 s for the other hIgG-coated series, as indicated. The 
adhesion probability for each cell pair was estimated from the running adhesion 
frequency at the last adhesion test (54% and 35% for CD16-hIgG, 10- and 5-s contact 
durations, respectively, and 3% for CD16-BSA, 5-s contact time). The specificity of the 
adhesions is seen from the dependence of adhesion probability on the presence of hIgG 
on the RBC surface. The feasibility of measuring adhesion kinetics is revealed from the 
dependence of adhesion probability on contact time. The stability of the running 
adhesion frequency after 50 test cycles is an indication of its adhesive detachment 
mechanism (receptor-ligand dissociation). (b) Illustration of another type of running 
adhesion frequency (solid curve), this time declining with increasing test cycle counts, 
which suggests a cohesive detachment mechanism (molecular extraction from the cell 
membrane). This type of irreversible behavior was found when the coated ligand was a 
specific antibody against the receptor (anti-CD16 mAb Leu-11b). The adhesion 
probability (dotted curve), determined by fitting of the entire running adhesion 
frequency curve to a Markov process model, decreases with the test cycle count, 
suggesting the gradual loss of functioning adhesion molecules in the contact area. Its 




Demonstration Of Binding Specificity
Also shown in Figure 4.2 is the fact that coating an irrelevant protein (BSA) 
instead of the ligands on the RBCs resulted in a dramatic decrease in the adhesion 
probability. The binding specificity is further demonstrated in Figure 4.3, which 
summarizes the results of experiments designed to address this question. As can be seen
under the same contact duration (5 seconds) and apparent area (3 µm2), hIgG-coated 
RBCs adhered with high probability to CHO cells transfected to express CD16a, but not 
to untransfected parental CHO cells (K1) or to CHO cells (A5) transfected with an 
irrelevant receptor (integrin αIIbβ3). Moreover, CD16a-expressing CHO cells did not 
adhere to uncoated RBCs or RBCs coated with an irrelevant protein (BSA). In addition, 
the adhesion probabilities were reduced to the nonspecific level of binding when the 
CD16a-expressing CHO cells were preincubated with the adhesion-blocking anti-CD16
monoclonal antibody (mAb) (CLB at 10 µg/ml), or when the hIgG-coated RBCs were 
preincubated with a soluble CD16a molecule (Fig. 4.3b). By contrast, preincubation of 
the CD16a-expressing CHO cells with an irrelevant mAb (X63) or of the hIgG-coated 
RBCs with an irrelevant soluble molecule (B7) had no effect (Chesla, Li, Nagarajan, 
Selvaraj, Zhu (2000)). These data established that the measured cell adhesions were 
mediated by the specific interactions betweenCD16a and hIgG.
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Figure 4.3: Demonstration of binding specificity. (a) The adhesion probability varied 
with the molecular combinations present or absent on the apposing cell surfaces. When 
CD16a was expressed on the CHO cell and the RBC was coated with hIgG, a high 
adhesion probability (45%) was observed. In contrast, when either no receptor ( ) or an 
irrelevant receptor ( IIb 3) was expressed on the CHO cell, low adhesion probabilities 
(5% and 4%, respectively) were observed for the same hIgG coating on the RBC. 
Similarly, when no ligand (-) or an irrelevant protein (BSA) coated the RBC, the 
adhesion probability was reduced to low levels (6% and 2%, respectively) for the same 
CD16a-expressing CHO cells. (b) The adhesion could also be inhibited by incubating the 
cells with blocking agents. The addition of the conditioned medium of hybridoma 
secreting anti-CD16 mAb CLB (contained ~10 µg/ml antibody) reduced the adhesion 
probability to 5%. Similarly, the addition of the conditioned medium of soluble CD16A-
secreting CHO cells (contained ~10 µg/ml sCD16A) decreased the adhesion probability 
to 8%. In contrast, conditioned media of hybridoma secreting an irrelevant mAb X63 and 
of CHO cells secreting an irrelevant soluble molecule B7 had no effect on the overall 
adhesion probability (35% and 42%, respectively). Each of the bars in A and B
represents mean ± standard error of data from two to four series of 50-200 tests, each at a 
contact duration of 5 s.
Dependence Of Adhesion Probability On Contact Duration
It can also be seen in Figure 4.2 that, when the contact times in a test sequence 
were prolonged from 5 to 10 s, the adhesion probability was increased. The dependence 
of Pa on t was systematically measured; the results (after subtracting the nonspecific 
binding) are shown in Figure 4.4. As expected, the adhesion probability increased with 
increasing contact duration initially and then reached a plateau. The initial transient phase 
contains information about kinetic rates, whereas the equilibrium association constant can
be derived from the steady state. Furthermore, for fixed contact durations, Pa increased 
a b
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with both the densities of the receptor and the ligand, as expected from the law of mass 
action.
Because Pa(t) = 1 - p0(t) is also solved from the master equations, comparing the 
measured and the predicted dependence of adhesion probability on contact time allows us 
to evaluate the kinetic rates. However, rate constants so calculated represent intrinsic 
properties if and only if the correct kinetic mechanism, i.e., the realistic order of the 
reaction, is assumed in Eq. 3-3. To identify the appropriate kinetic mechanism, the ability 
of the theory to account for the experiment was compared with the different 
stoichiometric coefficients assumed
Determination Of The Kinetic Mechanism
We first examine the order of dissociation. The Poisson type of simplified master 
equations was used to address this question, because the valences of the receptor and the 
ligand, vr and vl, need not be specified for such a case, as they are lumped into one of the 
two curve-fitting parameters, Acmrνrmlνlkf0 and Ac1 νbkr0. The equations were solved for 
various b values, and the errors between the predictions and the data were minimized by 
adjusting the lumped rate parameters for each of the four Pa versus t curves in Figure 4.4. 
The minimum χ2 (averaged over four curves) is plotted in Figure 4.5a against the b
value. It appears that the reverse reaction is of the first order, as this mechanism (νb = 1) 
is best able to reproduce the data (i.e., results in the lowest χ 2).
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Figure 4.4: Dependence of adhesion probability on contact time and receptor/ligand 
densities. The total adhesion probability (Pt) was converted into the probability of 
specific adhesion Pa = (Pt - Pn)/(1 - Pn), where the probability of nonspecific adhesion Pn
was Pt at ml = 0, i.e., measured with BSA-coated RBC), plotted as a function of the 
contact duration for each set of receptor and ligand densities, and fitted with the indicated 
theoretical solution (curves). A single set of kinetic rate constants (listed in Table 4-1) 
was used to fit all data corresponding to four different pairs of (mr, ml) values (indicated). 
The data (points) represent mean ± standard error of two to five series of tests of at least 
50 each to yield at least 400 total tests per data point.
The above conclusion that the CD16a-hIgG interaction obeys first-order 
dissociation greatly facilitated the remaining investigation for the kinetic mechanism, as 
the closed-form solution, Eq. 3-6, can now be applied to the data analysis. Not only is this 
handy to use, but it also suggests informative ways of presenting the data for hypothesis 
testing. It follows from Eq. 3-6 that
ln[ln(1 – Pa)
– 1] = νrlnmr + ν llnml + ln{AcK a
0[1 – exp( – kr
0t)]} (4-1) 
Thus, in ln[ln(1 - Pa) 1] versus ln ml (or ln mr) plots, the data should appear as linear for 
each fixed t and mr (or ml), and the slope of the line should be the valence of the ligand, νl
(or the receptor, νr). To test this argument, the two sets of Pa versus t data shown in 
Figure 4.4 that correspond to the samemr (= 652 µm 2) were replotted in Figure 4.6a as 
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ln[ln(1 - Pa) 1] versus ln ml for various t. It can be seen that, as the contact time changes, 
the y intercept of the ln[ln(1 - Pa)-1] versus ln ml line shifts, but its slope remains nearly 
the same (= 0.86 for the average of four constant time lines). Because νl can only take 
positive integer values, the data suggest that hIgG is a monovalent ligand for CD16a
We can now use the conclusion of νl = 1 to subtract the term involving the ligand 
on the right-hand side of Eq. 4-1. This allowed us to plot ln[ln(1 - Pa)-1] - ln ml versus ln 
mr in Figure 4.6b, using all four sets of Pa versus t data. It is evident that, for each fixed 
contact time, the data appear to line up in a straight line with a slope of approximately 
unity. Not only does this indicate the monovalency of CD16a binding; it also supports the 
validity of the present method for determining the kinetic mechanism. Further support of 
this argument is provided in Fig. 4.5b in which the minimum χ 2 is plotted against νr and 
νl. A single set of kinetic rates, Ackf0 and kr0, were used to fit all Pa versus t data for each 
pair of νr and νl values for all admissible νb [ ≤ min(νr, νl)] values. Again, the bimolecular 
binding mechanism between a single epitope on CD16a and a single binding site on the 
Fc domain of hIgG (νr = νl = 1) was bound to be best able to describe the data. This 
conclusion further supports the first-order dissociation mechanism, as νb cannot be greater 
than the smaller of νr and νl.
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Figure 4.5: Comparison of the abilities of various kinetic mechanisms to account for the 
data. (a) The solutions of the Poisson-type master equations with various orders of 
dissociation (νb) were fitted separately to each of the four sets of Pa versus t data from 
Fig. 4.4. The sum of squared weighted errors (χ2) from all of the curves was averaged and 
plotted against the νb value. (b) The four sets of data from Fig. 4.4 were simultaneously
fitted by the solutions of the full master equations (Eq.3-3), with various stoichiometric 
coefficients, νb, νr, and νl. The minimum χ 2 was calculated as a function of νr and νl. At 





Figure 4.6: Demonstration of the monovalency of CD16a-hIgG binding. (a) The two Pa
versus t curves from Fig. 4.4 that correspond to the same receptor expression level (mr = 
650 µm 2) but different ligand coating densities (ml = 380 and 1200 µm-2) were replotted 
as ln[ln(1 - Pa)-1] versus ln ml data (points) for each contact duration t (indicated) and 
fitted with a linear function (lines). The nearest integer of the slopes of these lines 
(indicated) is predicted to be the most probable value of νl, which is 1. (b) All curves 
were replotted as ln[ln(1 - Pa) 1] - ln ml versus ln mr data (points) for each contact 
duration t (indicated) and fitted with a linear function (lines) with the goodness of fit 
indicated by the R2 value. The nearest integer of the slopes of these lines (indicated) is 




Validating The T heoretical Predictions And Evaluating The K inetic Rate Constants
It follows from Equation 4.1 that, when r = l = 1 and for a fixed value of t, ln(1 
Pa) 1 should increase bilinearly with mr and ml. The slope of the ln(1 Pa) 1 versus mr
× ml line should be equal to AcKa0[1  exp( kr0t)]. These predictions were tested in
Figure 4.7 and were found to be well supported by the data. Minimizing the errors 
between the predicted and measured slope versus contact time relationship (Fig. 4.7b) 
makes it possible to evaluate the binding affinity (per contact area), AcKa0, and the reverse 
rate constant, kr0. To test the accuracy and reliability of these values, the kinetic rate 
constants were also calculated using each Pa versus t curve in Fig. 4.4 for various mr and 
ml levels, as well as fitting all of the data simultaneously (Table 4-1). Conversely, the kf0
and kr0 values evaluated from the fitting of one Pa versus t curve were then used to predict 
other Pa versus t curves obtained from independent experiments using different levels of 
mr and ml (not shown). The ability of the model to use only a single pair of rate constants
to fit a wide range of data, including five time points and four ligand and three receptor 
densities, not only attests to the validity of the method employed, but also suggests that 
the estimated parameters are indeed intrinsic molecular properties.
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Figure 4.7: Further demonstration of the bimolecular kinetic mechanism. (a) The 
probability of total adhesion Pt versus the product of surface densities (mr × ml) of CD16a 
and hIgG is shown in a semi log plot (Pt ≈ ln(1 - Pt)-1 for small Pt). For each contact 
duration t (indicated), the data (points) were fitted with a linear function (lines), and the 
goodness of fit was indicated by the R2 value. The error bars were computed from the 
original data according to the Gaussian error propagation law. (b) The slopes of the 
individual lines from (a) were plotted against t and fitted with the indicated equation. The 
ability of the theoretical model to fit the data well in both panels is another indication that 




Additional support for the theory was found when it was tested for the predicted 
functional form of the adhesion probability, i.e., that all Pa versus t data for the same 
receptor-ligand pair should collapse into a single (mrml) 1ln(1 - Pa) 1 versus t curve, 
regardless of the densities of the receptors and ligands (Figure 4.8). The four Pa versus t
curves shown in Figure 4.4 did indeed collapse in Figure 4.8. When the origin of the IgG 
ligandswas changed from human to rabbit, the (mrml) 1ln(1 - Pa) 1 versus t curve shifted, 
indicating different kinetic rate constants for different molecular pairs. Indeed, human 
CD16a binds twice as rapidly to, but dissociates half as rapidly from, RbIgG than hIgG, 
leading to a fourfold difference in affinity (Table 4-1), which is consistent with the 
affinity difference measured when the IgGs were in solution (i.e., 3-D affinity).
Table 4-1: Summary of kinetic rate constants
IgG origin mr (µm 2) ml (µm 2) Ackf0 × 107 (µm4 s 1) kr0 (s 1) AcKa0 × 106 (µm4)
Human 650 380 4.0  ± 1.5 0.36 ± 0.16 1.1
Human 650 1200 1.9  ± 3.7 0.13  ± 0.06 1.4
Human 1200 710 2.5 ± 0.94 0.42  ± 0.18 0.59
Human 4600 300 2.9 ± 0.52 0.35  ± 0.09 0.82
Human Combined data 2.6 ± 0.32 0.37 ± 0.06 0.72
Rabbit 1200 190 6.0 ± 0.42 0.25 ±  0.07 2.4
Rabbit 1200 360 5.2 ± 0.49 0.16  ± 0.05 3.3
Rabbit Combined data 5.7 ± 0.31 0.20 ± 0.04 2.8
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Figure 4.8: Validation of the functional form of the theoretical prediction. Data (points) 
from Figure 4.4 (hIgG group) plus those measured for IgG from a different species 
(rabbit) were converted into a logarithmic scale, divided by (mr × ml), plotted against t, 
and fitted with the indicated equation (curves). The theoretical solution predicts that, for 
the same receptor-ligand pair, data measured using different mr and ml values (indicated) 
should collapse into a single curve in this plot. Thus the difference in the two data groups 
reveals different kinetic rate constants for CD16a binding IgG of different origins (human 
and rabbit). As such, a single set of Ackf0 and kr0 (Table 4-2) was used to fit multiple data 
curves for the same receptor and ligand pair (CD16a-hIgG or CD16a-RbIgG). The error 
bars were computed from the original data, using the Gaussian error propagation law. 
Adhesions were measured at t = 0.5, 1, 5, 10 and 20 s. However, not all data were plotted 
at the exact time points, to avoid symbol overlap.
A Simple Graphic Representation
A simple graphic representation for estimation of the kinetic rates from the 
adhesion probability versus contact time data without using χ2 fitting of nonlinear curves 
is also available. The value of AcKa0 can be estimated directly from the slope of the ln[1 -
Pa(∞)] 1 versus mrml plot, where Pa(∞) is the steady-state value of the adhesion 
probability. This has been exemplified in Figure 4.7 (the 10- and 20-s lines in Fig. 4.7a or 
the corresponding points in Figure 4.7b). Similarly, the value for the reverse rate constant
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can be estimated directly from the time, t50, that is required for the Pa versus t data to 
achieve half-maximum,
kr0 = ln2t50
C(A cmrmlKa0) (4-2 a)
where C  varies between 0 and 1;  and its weak dependence  on AcmrmlKa0 can be  derived 
from Equation 3-6: 
C = 1
ln2
ln 1 + {ln[1 + exp(– AcmrmlKa




As can be seen from Figure 4.9, for the values of AcmrmlKa0 encountered in the 
present work (Table 4-1), C only varies between 0.7 and 0.9. Thus,
kr
0 ≈ t50
– 1 × 50% (4-2 c)
Above, the kinetic rates and binding affinity of the CD16a-IgG interaction using 
the developed micropipette method were quantitated. Additionally the question may be 
asked whether the membrane anchor (including the associated subunits) itself had any 
influence on these intrinsic binding parameters. The mechanisms that might cause such 
differences are also of interest. These questions are a natural progression of the initial 
research that I began at Georgia Tech: 1) by using existing radiographic protocols, I 
determined whether binding affinity differences exist between CD16a-TM and CD16b-
GPI to soluble hIgG and RbIgG, and 2) I determined the debonding force characteristics 
of IgG to CD16a using existing micropipette protocols and the methodology developed to 
determine the 2D kinetic rates of cellular adhesion.
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To answer the above questions, additional data was needed with different 
combinations of CD16 anchored molecules and different IgG molecules exhibiting 
different affinities. The different CD16 anchoring mechanisms are depicted in Figure 2.5. 
The data reported above was collected using the CD16a-TM isoform with its interaction 
with hIgG. To determine the effect of the anchoring mechanism on CD16 rates and 
affinity, first additional data was gathered using the CD16a-GPI isoform, again using 
hIgG as the ligand. Next the rates and affinity were determined for both CD16a-TM and 
CD16a-GPI for interactions with RbIgG and mIgG2a (Chesla, Li, Nagarajan, Selvaraj, 
Zhu (2000)).
The data shows that, in comparison to CD16a-TM, CD16a-GPI bound with faster 
forward rates and higher affinities to hIgG and rabbit IgG (RbIgG) but with a slower 
forward rate and a lower affinity to mIgG2a. Thus, the membrane anchor of CD16 
influenced its ligand binding kinetic rates and affinity, and the qualitative trend of such an 
effect was inverted when the ligand was changed. Furthermore, this effect exhibited the 
same pattern regardless whether binding was measured with membrane-bound ligands 
using the micropipette method or with fluid-phase ligands via competitive inhibition. The 
findings that the anchor effect flipped with different ligands and that the same results 
were observed in both two-dimensional and three-dimensional studies are important. 
They enable the following six possible mechanisms for the membrane anchor effect to be 
ruled out: differing lateral diffusivity, rotational flexibility, molecular orientation, binding 
site height, surface distribution, and functional clustering of the two molecules.
Furthermore, no major differential glycosylation between the two CD16a isoforms was 
found by SDS-PAGE analysis (Chesla, Li, Nagarajan, Selvaraj, Zhu (2000)). The 
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hypothesis is that there is a conformational difference between the two CD16a isoforms 
that causes the observed anchor effects. This proposed mechanism is also supported by a 
finding that whereas an anti-CD16 monoclonal antibody (mAb) bound with higher 
affinity for CD16a-GPI than CD16a-TM, another mAb reacted strongly with CD16a-TM 
but only weakly with CD16a-GPI, suggesting that an antigenic epitope was down-
regulated after the membrane anchor of CD16a had been changed from TM to GPI 
(Chesla, Li, Nagarajan, Selvaraj, Zhu (2000)).
The structural segments of cell surface receptors consist of distinct domains as 
follows: a glycosylated extracellular domain linked to either a transmembrane (TM) 
domain with a cytoplasmic tail or to a glycosylphosphatidylinositol (GPI) moiety without 
TM and cytoplasmic domains (Cross (1987), Low (1987)). The anchor can influence the 
function of a receptor. TM anchors of some receptors carry information for protein 
internalization and subunit association, whereas those of other receptors transduce signals 
(Klausner et al. (1990), Lanier et al. (1990)). The GPI moiety consists of a glycan core
sandwiched between ethanolamine and a lipid tail. Ethanolamine is covalently attached to 
the carboxyl terminus of the protein by an amide bond, whereas the lipid tail directly 
inserts into the outer leaflet of the membrane but does not cross the bilayer (Ferfguson et 
al. (1988)). The GPI anchor has been implicated in facilitating the lateral mobility of the 
protein on the cell surface (Zhang et al. (1991)) and enhancing receptor-mediated cell 
adhesion (Chan et al. (1991), Tozeren et al. (1992)).
As presented in Chapter 2, there are four known eukaryotic receptors that 
naturally exist in both membrane anchor isoforms as follows: neural cell adhesion
molecule, lymphocyte function-associated antigen 3, vascular cell adhesion molecule 1, 
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and Fcγ  receptor III (FcγRIII or CD16). The physiological significance of this coexistence 
of two distinct membrane anchor isoforms for the same receptor is not clear. As such, a 
comparison of the 2D to 3D kinetic rates and binding affinities for TM-anchored 
FcγRIIIa versus GPI-anchored FcγRIIIb is relevant and significant.
The Two-Dimensional Kinetic Rates Depended On The CD16 Membrane Anchor 
And This Dependence Varied with Ligand
The micropipette method quantifies the dependence of adhesion probability on 
contact time and densities of the receptors and ligands, as exemplified in Figure 4.4. To 
allow for direct visual comparison of the kinetic rates and binding affinity, the mass
action effect, manifesting itself in Figure 4.4 as an upward or downward shifting of the 
curves depending on the receptor and ligand densities (mr and ml), must be eliminated. 
This is achieved by a simple transformation of Equation 4-1 (with monovalent 
coefficients) into Equation 4-3.
( ) ( ) [ ])exp(1ln 1 11 talry kKAPmm rac −−=≡ − −− (4-3) 
It is evident that the far right-hand side of Equation 4-3 depends only on the 
binding affinity (Ka) and the reverse rate constant (kr) of the interacting molecules, 
provided that the contact area (Ac) is kept constant, as in the present study. Thus, this 
transformation collapses a family of Pa versus t curves for the same receptor-ligand pair
into a single curve on the transformed ordinate. Only when different interacting 
molecules are tested will the transformed binding curves shift, allowing for a direct 
visualization of the distinctKa and kr values.
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The transformed binding curves are shown in Figure 4.9 for each of the two 
human CD16a isoforms interacting with IgG from each of the three species. It is evident 
from Figure 4.9a that for hIgG the CD16a-GPI binding curve achieved a >2-fold higher 
level than the CD16a-TM binding curve at steady state (contact time t > 10 s). To test 
further this result, two additional ligands, IgGs from rabbit and murine, were examined, 
since they were known to interact well with human CD16. A similar trend was obtained 
when RbIgG was tested (Figure 4.9b). When mIgG2a was tested, however, an inverted 
result was observed. The CD16a-TM binding curve reached a ~7-fold higher equilibrium 
level than the CD16-GPI curve (Chesla, Li, Nagarajan, Selvaraj, Zhu (2000)). The 
plateau level of the transformed binding curve provides a direct measure for the binding 
affinity because the far right-hand side of Equation 4-3 approaches AcKa as t approaches
infinity.
The values for the reverse rate constant can also be visually compared from the 
transformed binding curves. It follows from Equation 4-3 that kr is equal to ln2 divided 
by the time required for the curve to reach half-maximum, t1/2, as shown in Equation 4-4.
tk r 2/17.0≈ (4-4) 
From the data shown in Figure 4.9, the t1/2 values appear to be comparable for the 
two CD16a isoforms interacting with the same IgG species, suggesting their similar
reverse rate constants.
Whereas the transformation given by Equation 4-3 makes the effect of the 
membrane anchor on kinetic rates and binding affinity readily visible without analysis, 
fitting Equation 4-3 to the data (Figure 4.9) allows for quantitative evaluation of kf, kr, and 
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Ka. The values of these two-dimensional kinetic properties are presented in Table 4-2, 
which quantitatively confirm the visual observations.
Table 4-2: Summary of two-dimensional CD16a-IgG kinetic rates and affinities.
CD16a IgG Ackf kr AcKa
10 6 µm4 s 1 s 1 10 6 µm4
TM hIgG 0.25  ± 0.11 0.34  ± 0.05 0.74  ± 0.3 
GPI hIgG 0.77  ± 0.29 0.42  ± 0.02 1.8  ± 0.7 
TM RbIgG 0.58  ± 0.05 0.24  ± 0.02 2.4  ± 0.1 
GPI RbIgG 0.70  ± 0.09 0.17  ± 0.02 4.1  ± 0.2 
TM mIgG2a 2.4  ± 0.26 0.31  ± 0.02 7.6  ± 0.7 
GPI mIgG2a 0.59  ± 0.27 0.54  ± 0.03 1.1  ± 0.5
Thus, the micropipette data revealed the membrane anchor of CD16a as a major 
determinant of its kinetic properties; it altered the forward, but not the reverse, rate 
constant and thereby also altered the binding affinity. Significantly, this effect varied with 
the ligand species, with the GPI-anchored CD16a having higher affinity for hIgG and 
RbIgG but lower affinity for mIgG2a than its TM-anchored counterpart. This "flipping" 
phenomenon is interesting and may be useful in understanding the underlying mechanism
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Figure 4.9: Transformed binding curves of CD16a-TM-  and CD16a-GPI-expressing CHO 
cells interacting with red blood cells coated with IgGs from human (a) and rabbit (b), and 
mouse (c). The adhesion probability data, exemplified in Figure 4.4, were transformed 
according to Equation 4-3 (the logarithm of the reciprocal of 1 - Pa was taken and divided 
by mr and ml) and then plotted against the contact time t. By normalizing the ordinate with 
respect to mr and ml, the family of curves corresponding to the same pair of interacting 
molecules but different densities of receptors and ligands collapse. Furthermore, the 
dependence of binding affinity Ka and reverse rate kr on molecular identity becomes 
apparent. The higher plateau level indicates a greater Ka; and a shorter half-time (t1/2, 
indicated) reflects a faster kr. The theoretical predictions (Equation 4.3, curves) were fit to 
each data set (points, mean ± S.E.) to evaluate the Ka and kr values, which are listed in 
Table 4.2. The number of cell pairs examined was 43, 17, 20, 22, 11, and 12 for the CD16a-
TM-hIgG, CD16a-GPI-hIgG, CD16a-TM- RbIgG, CD16a-GPI-RbIgG, CD16a-TM-
mIgG2a, and CD16a-GPI-mIgG2a curves, respectively. Each cell pair was repeatedly tested 





The CD16 Membrane Anchor Effect On Binding Affinity And Its Ligand 
Dependence Was Also Found In Three-dimensional Binding Studies
The preceding section represents the first application of the developed 
micropipette method for determining two-dimensional kinetic rates in a comparative 
study of the ligand-binding property of a cell surface receptor. Although this method has 
been carefully validated (Chesla et al. (1998)), it is important to further verify it by 
comparing its predictions with those derived from more established methodologies. For 
this reason, three-dimensional binding studies were conducted to address the following 
questions. Was the CD16 membrane anchor effect on ligand binding seen in Figure 4.9 a 
true indication of the structure-function relationship of the interacting molecules, a real 
reflection of the two-dimensional experimental conditions, or a mere artifact of the 
micropipettemethod?
Figure 4.10: Scatchard analyses of binding of 125I-labeled CLBFcgran- 1 Fab to CHO cell 
transfectants expressing CD16a-TM (squares) and CD16a-GPI (circles). Points are 
experimental data, and the solid lines are least square linear fits to the two data sets. The 
slope of each line equals the negative of the three-dimensional binding affinity, Ka, 
whereas the x intercept provides a measure for the receptor density. The results shown 
are representative. The mean and S.D. of all measured values are listed in Table 4-3. 
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The affinities of an anti-CD16 mAb CLBFcgran-1 in fluid-phase for both CD16a-
TM and CD16-GPI on CHO cells were first determined by Scatchard analysis (Figure 
4.10). The membrane anchor effect (in this case using the Fab fragment of CLBFcgran-1 
as ligand) again is apparent in Figure 4.10, with the GPI-anchored CD16a exhibiting a 
higher affinity than the TM-anchored CD16a. Because CD16 is a low affinity receptor for 
monomeric IgG, measuring CD16-IgG interactions by the Scatchard method is rather
difficult and results so obtained may not be reliable.
A competitive inhibition protocol using nonlinear curve-fitting based on Equation 
3-1 was therefore adapted. Representative data comparing the two human CD16a 
membrane anchor isoforms are presented in Figure 4.11a, b, and c using hIgG, RIgG, and 
mIgG2a respectively (Chesla, Li, Nagarajan, Selvaraj, Zhu (2000)). It is evident from 
Figure 4.11a and b, that CD16a-GPI had higher affinities than CD16a-TM for hIgG and 
RbIgG, as the same ligand concentration inhibited the CLBFcgran-1 binding to a greater 
extent. The fact that CLBFcgran-1 bound with a higher affinity to CD16a-GPI than
CD16a-TM (Figure 4.11) should lead to less, rather than more (as was the case), 
inhibition by hIgG or RbIgG. The situation using mIgG2a is different. Using mIgG2a the 
lower curve corresponds to CD16a-TM, which has a lower affinity than CD16a-GPI for 
CLBFcgran-1. Hence it would be easier to be inhibited even if mIgG2a were to bind both 
CD16a membrane isoforms with the same affinity. However, fitting Equation 3-1 to the 
data revealed that CD16a-TM indeed had a higher affinity than CD16a-GPI for mIgG2a,
as was in the two-dimensional case. The three-dimensional affinity results are 
summarized in Table 4-3 
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Figure 4.11: Competitive inhibition curves for determining the binding affinities of 
CD16a-TM and CD16a-GPI for IgG of three species. CHO cells expressing CD16a 
membrane isoforms were allowed to bind 125I-labeled CLBFcgran-1 Fab in the presence 
of varying concentrations of hIgG (a), RbIgG (b) or mIgG2a (c). Points are data 
presented as mean ± S.D. of triplicate wells, whereas each curve is a χ2 fit to that set of 
data using Equation 3-1. The mean and S.D. of the Ka values of each ligand to both 
CD16a-TM and CD16a-GPI are listed in Table 4.3. 
Table 4-3: Summary of three-dimensional CD16-ligand affinities.
Receptor CLBFcgran-1 hIgG RbIgG mIgG2a 
108 M 1 106 M 1
CD16a-TM 1.0  ± 0.2 (4) 0.25  ± 0.09 (5) 0.93  ± 0.17 (3) 0.41  ± 0.03 (2) 
CD16a-GPI 5.4  ± 0.2 (7) 2.1  ± 0.31 (3) 6.3  ± 0.9 (3) 0.11  ± 0.01 (2) 
CD16a-γ 0.97  ± 0.25 (2) 0.40  ± 0.1 (2) 0.57  ± 0.1 (2) 0.66  ± 0.1 (2) 
CD16a-ζ 0.61  ± 0.23 (2) 0.34  ± 0.1 (2) 0.80  ± 0.17 (2) 0.47  ± 0.21 (2) 
CD16bNA1 1.5  ± 0.2 (2) 0.032  ± 0.01 (3) 0.033  ± 0.004 (3) ND 





This work elucidates the how the receptor anchor mechanism can influence 
kinetic rates; compared with CD16a-TM, CD16a-GPI bound faster and with higher 
affinities to human and rabbit IgGs but slower and with lower affinity to murine IgG2a. 
The same differential affinity patterns were observed using soluble IgG ligands. A 
monoclonal antibody bound CD16a-GPI with higher affinity than CD16a-TM, whereas
another monoclonal antibody reacted strongly with CD16a-TM but weakly with CD16a-
GPI. No major differential glycosylation between the two CD16a isoforms was detected 
by SDS-polyacrylamide gel electrophoresis analysis. The hypothesis is that a 
conformational difference is the mechanism underlying the observed anchor effect, as it
cannot be explained by the differing diffusivity, flexibility, orientation, height, 
distribution, or clustering of the two molecules on the cell membrane. These data 
demonstrate that a covalent modification of an Ig super family receptor at the carboxyl 
terminus of the ectodomain can have an impact on ligand binding kinetics (Chesla, Li, 
Nagarajan, Selvaraj, Zhu (2000)).
Effect Of Ligand O rientation And Availability
During the course of data acquisition to complete the specific aims of this thesis, 
it was also observed that ligand orientation has a dramatic effect on the kinetic 
parameters calculated using the developed system. Again, observation of these ligand 
orientation effects was a natural progression from the work previously presented. This 
section will examine how the surface presentation of adhesion receptors influences cell 
adhesion. The micropipette adhesion frequency assay was used to quantify how the 
molecular orientation of adhesion receptors on the cell membrane affected two-
dimensional kinetic rates of interactions with surface ligands. Interactions of CD16a with 
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the respective ligands or antibody were used to demonstrate such effects. Randomizing 
the orientation of the adhesion receptor lowered two-dimensional affinities of the 
molecular interactions by reducing the forward rates but not the reverse rates. In contrast, 
to the ligand orientation effects on two dimensional binding properties, the soluble 








Figure 4.12: Schematics of rabbit anti-human RBC IgG that was oriented uniformly via 
binding to RBCs or irrelevant RbIgG was oriented randomly by coupling via CrCl3.
These results demonstrate that the orientation of an adhesion receptor influences 
its rate of encountering and binding a surface ligand but does not subsequently affect the 
stability of binding. The different RbIgG orientations are described in Figure 4.12. The 
three dimensional binding characteristics of RbIgG are presented in Table 4-3. The non-
specific RbIgG was used to determine this 3D affinity. The 3D affinity of the anti-RBC 
RbIgG to CD16a is assumed identical as the molecular differences in the RbIgG 



























Figure 4.13: 2D kinetic reverse-rates and effective affinities of CD16a for uniformly or 
randomly oriented RbIgG. Adhesion experiments were performed using two sets of 
receptor and ligand densities for each orientation: mr × ml = 1200 × 40 and 240 × 40 µm-4 
for uniformly captured RbIgG and 240 × 190 and 1200 × 360 µm-4 for randomly coupled 
RbIgG, respectively. The reverse rates, kr0, and effective binding affinities, AcKa0, for 
CHO cell CD16a interacting with uniformly (solid bars) and randomly (open bars) 
oriented RbIgG were obtained by fitting.
Measuring Extraction Probability Of Receptors From The Cell Membrane
Previous micropipette protocols mainly focused on the resolution of detachment 
force from the observed deflection in the red cell membrane. The interpretation of the 
micropipette force data requires the knowledge regarding the detachment mode, i.e., via 
dissociation at the receptor-ligand binding site or via extraction at the membrane anchor 
of either the receptor or the ligand, as both detachment modes may require similar levels 
of force. Observation of these detachment mode effects was also a natural progression 
from the work previously presented.  During the course of this thesis, a quantitative 
method to address the question of detachment mode was developed. The key 
observations were the two qualitatively distinct features seen when a large number of 
repeated adhesion tests were performed sequentially on the same contact area using a 
single pair of cells. One of these, characterized by a uniform distribution of adhesion 
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events amongst all tests and a stable running frequency, may be called reversible binding 
(Figure 4.14a). It is suggestive of dissociation of the receptor-ligand bonds; and this 
behavior was seen when the receptor-ligand interaction was of low affinity (3D Kd ~ µM, 
referred to as a weak bond). The other of these, characterized by a concentration of 
adhesion events near early tests and a declining running frequency, may be called 
irreversible binding (Figure 4.14b). It is indicative of disruption of the membrane anchor 
of either the receptor or the ligand; and this behavior was seen when the receptor-ligand 
interaction was of high affinity (3D Kd ~ nM, referred to as a strong bond). To 
quantitatively measure the likelihood of molecular extraction I, a Markov model was 
constructed for the statistical analysis of the running adhesion frequency, Pa, (Figure 
4.14).
Pa = 1 – 1i expΣj = 1
i
{– A cm rm lK a0(1 – e – k r
0 t)[1 – ImmaxK a0(1 – e – k r
0 t)] j – 1} (4-5)
where i is the cycle number in the repeated adhesion tests,mmax =max(mr,ml). When I = 0, 
Eq. 4-5 reduces to Eq. 4-6.
Pa = 1 – exp{- Acmrml Ka0 [1 - exp(-kr0 t )]} (4-6) 
Comparisons between the expected and measured running adhesion frequency vs test 
cycle count curves are shown in Figures 4.14a and b, for the reversible (low I) and 
irreversible (high I) cases, respectively. Figure 4.14c shows the systematic determination 
of the extraction probability for TM- or GPI-CD16a interacting with either a natural 
ligand, hIgG, or a mAb directed against CD16 (Lue-11). Here the extraction probability, 
I, was determined by a χ2 error minimization of the data using equation 4-5 as a model. 
As expected, when the receptor-ligand bond was strong (i.e., of high affinity), it was 
more likely to uproot the molecule from the cell membrane. Similarly, when the receptor 
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membrane anchor was strong (i.e., TM-linked), it was less likely to be extracted if 
extraction was to occur. By comparison, if the extraction was unlikely, as in the weak 
bond case, the anchor strength had no effect. These data demonstrate our ability to 
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Figure 4.14: Running frequency vs adhesion test cycle count curves for reversible (a) and 
irreversible (b) binding between CD16a-TM expressing CHO cells interacting with RBC 
coated with hIgG (a) or anti-CD16 mAb Lue-11 (b).  Summary data (mean ± standard 
error) for the extraction probability, I, for four cases of strong (TM) or weak (GPI) 
anchored CD16a forming strong (Lue-11) or weak (hIgG) bonds with ligands. Also 




Micropipet Force Determination Precision
The detachment force was extracted from the CD16-IgG reactions observed using 
the method described in Chapter 3. In addition to the detachment force, an estimate of the 
micropipette systems precision was also calculated. The precision assessment first 
required the determination of the force-deflection relationship using a finite difference 
method. Analytical solutions (via perturbation and linearization) to the membranes 
mechanics problem are also available in our lab and can be compared to the finite 
difference computational solution. 
Each of the techniques shows good agreement in their solutions. The greatest 
difference in the predicted membrane shape under a point load occurs at the apex of the 
cell. The deformed shape near the apex of the aspirated RBC predicted from each of the 
three solution techniques is plotted in Figure 4.15. The linearized solution shows the 
greatest propensity toward cone formation. This may be interpreted as the solution whose
contribution from the binding rigidity is the smallest. The computational and perturbation 




















Figure 4.15: Magnified non-dimensional view of the RBC apex loaded by a point force.
The linearized solution shows the greatest propensity toward cone formation. This may 
be interpreted as the solution whose contribution from the binding rigidity is the smallest. 
The computational and perturbation techniques show good agreement especially in the 
shape of the cell apex.
The force versus deflection relationship predicted from each analysis under 
similar conditions are shown in Figure 4.16a in nondimensional form and shows good 
agreement. Agreement is close between the computational and linearized solutions. This 
contrasts the results at the cell tip and illustrates that the majority of the cell deformation 
in the z direction occurs away from the tip.
The RBC transducer compliance coefficients are plotted in Figure 4.16b against 
the deflection. This plot illustrates the assumed linearity of both analytic solutions; 
however, the nonlinearity of the problem is clearly evident in the computational solution. 
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Figure 4.16:  (a)  Force versus deflection relationship of the three different solutions to 
the RBC membrane mechanics equations.  (b) The compliance coefficient of each 
solution plotted versus deflection.
Although all solutions to the membrane equations show good agreement, the 
validity of the analyses has not yet been demonstrated. Accordingly, an experiment was 
devised to load an aspirated RBC transducer with a known force in order to calibrate its 
deflection. The experimental set up illustrated in Figure 4.17 and 4.18 utilizes a fully 
aspirated RBC that acts as a force imposing piston. Leakage effects around the piston 
during this experiment were neglected. It has recently come to our attention that this 




Briefly a RBC’s were osmotically preswollen and allowed to come in contact with 
a anti-RBC antibody coated bead. The RBC on the left hand side was aspirated into a 
smaller pipette. The geometry of the aspirated pipette is in agreement with the geometry 
depicted in Figure 4.17. Simultaneously, the right hand side RBC was aspirated into a 
larger pipette which was matched to the RBC diameter size. This experiment was 
repeated on several occasions with different pipette sizes and different cell sets. The 
sensitivity of the left hand side pipette was tuned by controlling the left hand side suction 




Figure 4.17:  A schematic showing the force transducer arrangement used to validate the 
calculated spring constant of the RBC deflection models.
Figure 4.18:  The transducer validation experiment in which a partially aspirated RBC 
transducer is loaded by a fully aspirated RBC piston.
Comparing a representative force versus deflection relationship predicted from 
computational analysis to validation data in Figure 4.19a, again good agreement is seen.  
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Figure 4.19b presents the error of the calculated versus measured force. As shown in 
equation 4-7, the measured force from the force validation experiment is heavily 
dependent upon the accuracy of the pressure measurement in the right hand side pipette
[ ] [ ]επ leakagepipetmeasured rf P −∆= 2 (4-7)
An accuracy of 0.05 mm H2O is expected in the measurement of the pipette
pressure. The scatter in the measured force data illustrated in Figures 4.19 reflects the 
accurate suction pressure reading sensitivity. The predicted standard deviation of 
approximately 30%, shown in Figure 4.19b, is derived assuming an accuracy of 0.05 mm 
H20 in piston suction pressure. Taking into account the error associated with the pressure 
measurement, the leakage affects and minor errors in bead displacement measurement 
and left hand side pipette cell radius, pipette radius or pressure measurement, the 



















































Figure 4.19:  (a) Comparison between the predicted and measured force versus 
deflection relationship.  (b)  Histogram of error between the validation data and  matched 
computational solutions. An error of 30% is expected solely as a result of suction 
pressure inaccuracy of 0.05mm H2O.
It has previously been illustrated that the micropipette transducer is sufficiently 
sensitive to make it an attractive force measurement devise; however, assessing the 
accuracy of the piconewton force measurement requires a summed error propagation 
across all independent parameters, not just the observed deflection. Random errors in the 
measurement of x, y, or z can lead to error in the determination of f, when f is defined in 
equation 4-8. Because random errors can be defined as either positive or negative errors 
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in the measurement of x, y and z, the error associated in f is usually written as a function 
of (df)2. Then, using equation 4-8, (df)2 takes the form of equation 4-9. If the measured 
variables are not correlated, the cross terms average to zero, i.e., dx dy = 0, dy dz = 0, and 
dx dz = 0 because dx, dy, and dz are both positive and negative values. Then df = (df)1/2. If 
the standard deviation (σ) of the measurement is assumed equal to the differentials, 
equation 4-10 is the error propagation formula.






























































































































































Table 4-4 presents the accuracy in which the independent parameters can be 
measured in column 1. Using equation 4-10, the propagated error from the individual 
measurements can define the precision of the overall force measurement. The 
measurements of concern are the suction pressure of the aspirated RBC, the measured 
cell radius, the measured pipette radius, the measured RBC deformation, the bending 
coefficient (determined from literature) and the shear constant (determined from 
literature). In this analysis the suction pressure accuracy is again assumed as 0.05 mm 
H2O. Because the configuration of the aspirated RBC is not in the configuration of a 
piston, the dependence of the force measurement on suction pressure is less critical. 
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Therefore, the propagated error due to accuracy in pipette suction pressure is the least of 
all the identified measured parameters as shown in Figure 4.20a. A useful purpose 
justifying the determination of the propagated error is in determining the principle source 
of measurement error and suggesting improvement in that area. Figure 4.20a and Table 
4.-4 both indicate the major source of error in the force calculation is the deflection 
measurement. The measured deflection in the case of an experimental configuration 
according to Figure 4.17 is expected to much less then the deflection measurement of an 
experimental configuration according to Figure 3.3. In the experimental case of Figure 
4.17, the binding is mediated by antibody bound to plastic bead. The position of the bead 
can be more certainly determined. In the experimental configuration depicted in Figure 
3.3, the binding is mediated by receptors and ligand expressed on the surface of apposing 
cells. While binding measured using membrane bound molecules is more physiologic the 
RBC edge is less certainly determined than is a bead edge or centroid. Because the 
deflection measurement accounts for much the propagated error in the experimental 
system, thought should be given to it’s optimization towards the experimental goals. 
Image analysis may be used to improve the accuracy of edge determination of the RBC 
membrane, although this step is time and cost sensitive.
Another critical measured parameter with respect to the proper determination of 
force in the membrane deformation model is the aspirating pipette radius. An accuracy of 
the pipette radius measurement of 100 µm was used in Table 4-4. This accuracy assumes 
that a correction is available for an apparent pipette radius measurement determined from 
the binding experiment images. Without correction the accuracy of the pipette radius may 
be as low as 250 µm and the propagated error could be more than double of its reported 
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value in Table 4-4. The relationship used to correct from the apparent diameter to the true 
diameter can be developed from pipits whose radii are first determined when immersed in 
diH2O then in oil. Pipettes immersed in oil will produce more accurate determinations of 
their radii. Alternatively, the pipette radius may be determined using a scanning electron 
microscope then in diH2O immersion. Using these methods a relationship between the 
apparent and true pipette radii may be determined. The apparent pipette radius should be 
converted into the true radium before force calculation are attempted using the RBC 
membrane experimental technique.
The bending constant or binding modulus is also a critical parameter with respect 
to the determination of force in the membrane deformation model. The influence of the 
bending modulus on the force measurement error is a justification and validation of 
including the bending terms in the governing equations. As shown in Figure 4.20b, good 
agreement is shown between the propagated error calculated using both the theoretical 
and computational models. This agreement is an indication that the assumptions in each 
model (independent in each case) do not result in significant errors. 
There is consistent agreement between the propagated errors calculated using both 
the analytical and computational methods for all the other parameters except the cell 
radius measurement which accounts for a difference between the two methods of over 
600% as shown in Figure 4.20b. The cell radius term in the computational model tends to 
cancel itself out in the discritization of the problem. The theoretical solution indicates that 
cell radius errors can propagate significant errors to the force calculation, although less 
than both the pipette radius and deflection measurements. One the sources of cell radius 
measurement error is a band width which is visualized at typically 0.5 µm as shown in 
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Figure 4.21. In order to reduce random propagation of error into the force calculation, the 
cell radius should be consistently measured on the inside of the band. To reduce the 
systematic error propagation due to errors in cell radius measurement, a relationship can 
be constructed between the true and apparent radius using area or volume conservation 
experiments.
Table 4-4: Expected accuracies for the independent parameters and their influence on the 
overall accuracy of the force calculation for the micropipette piconewton force 
transducer.
PARAMETER
        (Xi)
ACCURACY
       (σXi)












X iσ σ∂ ∂= × =∑(( ) )
2
      0.275 pN
       2.10 pN
       2.81 pN
       3.31 pN
       1.50 pN
             ----
5 pN
        0.05 mm H2O
        0.250 µm
        0.100 µm
        0.05 µm
        1E-19 J
        1E-5 N/m
 Computational
      0.23 pN 
      0.27 pN
      1.71 pN
       2.14 pN
       1.3 pN
       0.26 pN
3 pN
Examination of Table 4-4 indicates that the summation of all individual errors 
predicts an expected standard deviation of 3 to 5 pN out of a 40 pN calculated force. In 
this manner we estimate that the precision of the membrane technique for force 






















































































































Figure 4.20: (a) The propagated error as determined by the method outlined in equations 
22-24 using the computational model with parameters accuracies listed in Table 1. (b) 
The difference between the propagated error using the computational and theoretical 
models.
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Figure 4.21: A RBC used as a force determination device. The RBC configuration does 
not utilize a bead to mediate binding. Although the expression of receptor and ligand 
within the binding area may be more physiologic and binding statistics more relevant, the 
determination of the red cell deformation in the z direction is less certain due to the 
interfering bands of each cell. Image analysis across the entire red cell membrane can 
increase the certainty of the red cell deformation measurement.
The sensitivity of the micropipette piconewton force transducer has made it 
attractive to use, but the precision of the devise has not been addressed.  This work 
indicates that even without sophisticated image processing to improve the parameter 
accuracies, the expected standard deviation is small at +/- 5 pN when measuring forces in 
the 40 pN range. This sensitivity was achieved using both analytical and computational 
models of the RBC under a point load at the cell apex. Good agreement was 
demonstrated between the models and the assumptions imposed on the linearization of 
the governing equations in the analytic solutions appear validated. The propagation of 
error was also addressed using both the analytic and computational models. Again, good 
agreement was demonstrated between the error predictions.
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Quantal Behavior Of Observed CD16 Binding Events
A discussion of the statistical basis for the existence of single bonds has been 
introduced. It is useful to recall that the developed micropipette device collects data in 
two modes: force and event data. Previously, a theory was developed that allows the 
determination kinetic rates form the event data. Here both the adhesion probability and 
debonding force data are gathered with the goal of presenting evidence of quantal 
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FIGURE 4.22: Detachment force histograms, measured by micropipette with constant 
rate ramping, of IgG-coated RBC from CD16a-expressing CHO cells, performed in a 
way similar to those described in Appendix II. Inserts: Probability distribution of bonds, 
pn, that mediate the observed adhesions, predicted by the Poisson distribution from the 
measured adhesion probability, Pa|0, from the data in each panel. (a) All data, 1200 points 
at an average Pa|0 of 0.47. (b) Subpopulation of A, 100 points at an average Pa|0 of 0.76. 
(c) Subpopulation of A , 100 points at an average Pa|0 of 0.13.
An appealing argument for seeing single bonds is the appearance of quantal 
behavior in the measurements of low number molecular interactions. This was initially 
observed in histograms of rupture (or unbinding) forces of biotin/avidin interactions 




al. (1994). This kind of histogram is exemplified in Figure 4.22, which was obtained by 
the micropipette technique using human immunoglobulin G (IgG) coated RBC 
interacting with CD16a-expressing Chinese hamster ovary (CHO) cells. The histogram of 
1200 forces, measured from membrane elongation of the RBC that was retracted at a 
constant rate, peaks at bins of 15, 40 and 55 pN, which appear to be integer multiples of a 
quantal unit 18 pN (Fig. 4.22a). The frequencies of occurrence of these peak forces seem 
to correlate with the probabilities pn of having 1, 2, and 3 bonds (Fig. 4.22a insert), 
calculated from the average Pa|0 (= 0.47) using Poisson statistics. A subpopulation of 
these, 100 forces that were measured at a high Pa|0 (= 0.76) value, resulted in a histogram 
with the same peak locations but altered relative heights (Fig. 4.22b). These heights again 
correlate with the pn, which is now redistributed towards more likely having multiple 
bonds (Figs. 4.22b insert). Another subpopulation of 100 forces that were measured at a 
low Pa|0 (= 0.13) value resulted in a histogram with leftward shifted peak locations (Fig. 
4.22c). This is likely due to nonspecific binding, which comprises ~7% of total binding 
with much smaller rupture forces
One interpretation of histograms such as those shown in Figure 4.22 is based on a 
deterministic view: A single bond should have a defined strength below which it would 
remain intact and above which it would fail, n bonds would have an overall strength n
times that of the single bond strength. Applying this view to analyze the rupture force 
histogram, the quantal unit was interpreted as the single-bond strength (Florin et al. 
(1994)). However, such a deterministic view may not be valid at low loading rates (Zhu 
et al. (2000)). Recently more and more data support a probabilistic view: Noncovalent 
bonds dissociate stochastically, resulting in random rupture forces of a broad distribution, 
86
which is governed by the force-dependence of reverse-rate (Bell (1978), Evans et al. 
(2001 and 1995), Merkel et al. (1999), Zhu et al. (2000)). Unless the loading rates are 
sufficiently high, there may be significant overlaps among distributions of forces required 
to rupture clusters of different number of bonds, which obscures their discrimination 
(Zhu et al. (2000)).
The term quantal behavior is generally used to describe measurements that appear 
to behave as superposition of a low number of “elementary quantities”. In essence, a 
quantal binding unit possesses invariant characteristics of measurements as they become 
less and less frequent, often resulted from the number of interactions involved being 
progressively decreased. Besides the rupture force case exemplified in Figure 4.22, 
quantal behavior has also exhibited in other forms. The point-attachments observed in the 
micropipette experiments behaved as quantal binding units because they appeared to 
form independently of each other and with equal probability, regardless how much their 
frequency of occurrence decreased. In the flow chamber experiment, while the frequency 
of cell tethering should decrease with decreasing site density, the distribution of the 
observed tether lifetimes should not change in the low site density regime where single 
molecular interaction is expected to be predominant. This kind of “quantal behavior” has 
indeed been observed, which has been used to argue that the observed tethering events 
are supported by single bonds (Alon et al. (1995)).
However, although single bonds must behave as quantal binding units, quantal 
behavior does not necessitate single bonds, i.e., quantal behavior is a necessary but 
insufficient condition for single bonds. There are several caveats that can critically affect
data interpretation. The questions are: Does the quantal binding unit represent the 
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elementary binding unit or the smallest detectable unit or is the elementary binding unit a 
single bond or a cluster of bonds?
Observation Of FcγRIII Mediated Phagocytosis At The Single Cell Level:
Fcγ receptors are a critical link between the humoral and cellular arms of the 
immune system. They are expressed on hematopoietic cells and result in a wide array of 
cellular responses that include the release of inflammatory mediators, lymphokine 
production, cytotoxic triggering, cell activation, regulation of antibody production, and 
phagocytosis of antibody coated particles. As previously mentioned, there are three major 
classes of Fcγ receptors. Many cells coexpress more than one type of Fcγ receptor; 
moreover each type is polymorphic and expressed in different structural forms making 
experimental procedures difficult to design that isolate the source of a specific cellular 
function to a particular Fcγ receptor type. Controversy has surrounded the role of CD16b 
and the immune function of phagocytosis. Because CD16b is GPI anchored and does not 
require coexpression with the γ or ζ subunit, it was theorized not to be able to signal for 
phagocytosis. Some experimental results have implicated this to be the case, however, 
here CD16 was transfected into CHO cells to remove the influence of other Fcγ receptors 
for the experimental design. The link between the CD16 form and phagocytosis function 
was investigated at the single cell level. 
The direct visualization of the phagocytosis of EA by CHO cells at the single cell 
level was accomplished using micropipette manipulation. Previously this technique was 
used to observe the phagocytosis of yeast by macrophages. The phagocytosis described 
here occurred over a period of 15 minutes. The ingestion of the EA was confirmed using 
an ultrasensitive liquid nitrogen cooled CCD camera under epi-fluorescence illumination. 
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The EA, when viewed separately was autofluorescent. The CHO cell, when viewed 
separately, was not autofluorescent. After engulfing the EA, however, the CHO cell 
became fluorescent. Because CHO cells are not normally capable of phagocytosis, these 
data confirmed that CD16a expressing CHO cells could phagocytose EA and confirmed 
the phagocytosis data derived from colorimetric and fluorescent methods. Together, these 
results demonstrate that GPI anchored CD16b alleles differ from CD16a in their ability to 
mediate phagocytosis. Futhermore, since studies with other FcγRs have shown that CHO 
cells lack the phoagocytic pathways mediated by the cytoplasmic domain of FcγRs, the 
phagocytosis of EA by CHO cells stably transfected with C16a and CD16a-subunit 
chimera provides an ideal system to dissect the phagocytic signaling pathways mediated 
by these FcγR-associated subunits
Figure 4.23: Sequential photomicrographs of phagocytosis of EA by a CHO cell 
expressing CD16a. The human erythrocytes were opsonized with CLBFcgran1, an anti-
CD16 mAb, and allowed to adhere to CHO cells in a micromanipulation chamber. A 
CHO cell with a bound EA (indicated by arrow) was captured by a micropipette (a) and 
the entire phagocytic process (b and c) was viewed with brightfield microscopy, and the 
images were recorded using a closed circuit video system.
a b c
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Figure 4.24: Brightfield (a, c, and e) and fluorescent (b, d, and f) images of a human EA 
(a and b), a CD16a-positive CHO cell (c and d), and a CD16a-positive CHO cell that has 
engulfed an EA (e and f). The fluorescent images were obtained using an ultrasensitive 
liquid nitrogen-cooled CCD camera. No fluorescent dyes were used; therefore, the 
images seen were from autofluorescence of the cells. The fluorescent images shown in b, 
d, and f were the same cells as those brightfield images shown in a, c, and e. It can be 
seen that the originally nonfluorescent CHO cell (d) became fluorescent after engulfing 










The Method Measures Zero-Force Rate Constants
One of the major goals of this thesis was to develop a method to measure 2D 
kinetic rates when both of the interacting molecular species are anchored to apposing 
surfaces, as in the case of cell adhesion. An interesting feature of this method is that the 
chemistry of receptor-ligand binding is quantified mechanically. Because it is well known 
that applied forces can influence the binding kinetics (Bell, 1978), the question naturally 
arises: At what force level were the kinetic rates measured by the present method? The 
answer is that kf0 and kr0 represent rate constants at zero force, as indicated by their
superscript. This is a critical contention, for without it, all of the analytical solutions to 
the master equations would have no longer been valid (Piper et al., (1998)).
The reason for the above contention is that, during the contact period, the pipette 
impingement force that pushes the two cells together is most likely borne by the 
membrane and/or cytoskeleton support rather than by the receptor-ligand bonds. 
Although at the end of the contact period the bonds (if adhesion occurs) are stretched and 
broken as the cells are being pulled apart, this only serves to provide a signal to the 
observer of whether or not adhesion occurred during the given contact time. It is 
necessary to apply force to break all bonds for the adhesion test to be repeated in the next 
cycle; but this takes place at a later time. The contact period ends at the instant when the 
piezo-driven pipette starts to pull the cells apart. Moreover, care was taken to ensure that 
the rate of force application was sufficiently fast that the time it took to break the contact 
was negligible compared to the shortest contact duration tested (see below). In other
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words, in the present method, one counts the occurrence of adhesion events in the contact 
time when no tensile force is applied, instead of measuring the time required for the 
forced dissociation of the preformed bonds in the postcontact adhesion-detection phase.
The latter measurement, i.e., lifetime of stressed bonds, also contains kinetic information; 
and this is similar to the flow chamber experiment (Alon et al., (1995, 1997); Chen et al., 
(1997)). Thus, despite the fact that the formation of adhesive bonds can only be detected 
when they are broken by externally applied forces, the rates measured by the present 
method are those of spontaneous reaction in the absence of force.
The Method Measures Receptor-Ligand Binding
A useful extension from the above line of reasoning is that this micropipette 
protocol ensures that the measured rate constants represent the kinetics of reversible 
binding of receptors and ligands rather than their irreversible extraction from the cell 
membrane. The latter possibility always arises when the assay involves cell detachment 
(Evans et al., (1991)). This thesis develops a novel method of addressing this question 
quantitatively. The details of this approach were described in the results section, the key 
observation is that the binding evolution curves such as those exemplified in Fig. 4.14 
exhibit two qualitatively different features. One is characterized by the evenly distributed 
positive adhesion scores among all tests and a stable running frequency as the test cycle 
count becomes large (Fig. 4.14a). The other is characterized by the concentration of 
positive adhesion scores in the earlier tests and a declining running frequency with 
increasing test cycle count (Fig. 4.14b). The basic argument is that the former reversible 
behavior is suggestive of dissociation at the receptor-ligand binding site (adhesive
detachment mode), whereas the latter irreversible behavior is indicative of disruption at 
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the protein-membrane anchor site (cohesive detachment mode). It was found that the 
detachment modes were correlated with the types of molecular bonds involved (e.g., 
receptor-ligand binding versus antibody-antigen binding) (Chesla et al., (1995)). A 
quantitative measure of the extraction probability, or irreversibility, can be derived from 
the statistical analysis of the binding evolution curves (Chesla et al., (1997)).
The receptor (CD16a) and ligands (IgG) employed in this work were found to 
form weak bonds that would most likely dissociate at detachment. In fact, analyses of all 
of the binding evolution curves that gave rise to all of the adhesion probability data shown 
in Figure 4.4 demonstrated small probabilities of uprooting compared to the extraction 
probability in the case in which the bonds were mediated by Leu-11b-CD16a binding 
(Fig. 4.14b). While this low extraction probability is not required for the insurance of the 
rate constants determined by the present method to be those governing the binding of 
receptors and ligands rather than their membrane anchoring, it does justify the use of the 
running frequency at the last test as the best estimate for the adhesion probability. For 
declining running frequency, the measurement of adhesion probability requires fitting of 
the entire binding evolution curve to a Markov process model, as exemplified in Fig. 
4.14b. Unlike reversible binding, where the adhesion probability is independent of the test 
cycle count, the adhesion probability for the irreversible binding decreases with the test
cycle count. Nevertheless, its extrapolated initial value before the first test can be used for 
the purpose of employing the present method. Using such initial Pa data, the theoretical 
analysis described herein can still be applied to evaluate the kinetic rates for receptor-
ligand binding, despite the fact that measurement of this binding probability results in 
uprooting of receptors and/or ligands in such a case (Chesla et al., (1997)).
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Further Support For The Poisson Approximation
The described micropipette method includes a systematic approach to determining 
the kinetic mechanism. The 1:1 stoichiometry of the 2D adhesion determined by the 
present work is in agreement with that measured in 3D binding (Ghirlando et al., (1995)). 
The analyses presented in the Results section have clearly demonstrated the feasibility 
and illustrated the strategy of the approach. The analysis was greatly enhanced by the 
closed-form solution, Eq. 3-5, which forms the basis of several novel graphical 
representations of the data (Figs. 4.6-4.8). From Fig. 3.2, the condition for the Poisson
type of approximate solution (Eq. 3-5 if b = 1) to be valid is Acmmin  ( r/ b) n , which, 
when all stoichiometric coefficients are unity, becomes Ka0mmax  1. From the values 
listed in Table 4.1, it can be seen that this condition is satisfied for all mmax values tested,
justifying the use of the Poisson approximation. When Pa is plotted against the average 
number of bonds, n  (Fig. 5.1), all of thePa versus t data shown in Fig. 4.8 collapse into a 
single curve, regardless of the individual values of kf0, kr0, mr, ml, and t, further supporting 
the Poisson approximation and demonstrating the same kinetic mechanism for the two 
IgG ligands from different origins.
Comparison To The D eterministic Kinetic Model
In addition to the master equations, Eq. 3-3, its deterministic counterpart, the large 
system limit of Eq. 3-4a (with n( r+ l) = n( b) = 0), or rather, that of the Poisson 







ν l – kr0 <n>A c (5-1)
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was tested for the ability of its solution ( n /Ac) to fit the measured Pa versus t
data. Given the nearly linear relationship between Pa and n  when they are small (see Fig. 
5.1), it is not surprising that Eq. 5.1 was also able to fit the data, yielding comparable rate 
constants (not shown)
Figure 5.1: The probability of specific adhesion, Pa, was plotted against the average bond 
number, n , which was calculated based on Eq. 3.6b, using the two pairs of evaluated 
kinetic rate constants (Table 4.1, the two "combined data" rows for human and rabbit 
IgG, respectively). All data (points) collapsed into a single curve, which is in excellent 
agreement with the indicated theoretical solution (curve). The error bars were computed 
from the original data by using the Gaussian error propagation law.
However, it cannot be emphasized enough that major conceptual differences exist 
between the deterministic and probabilistic viewpoints. In large systems appropriate for 
the deterministic description, the fraction of molecules in the bound state is small 
initially; and only when the contact time approaches the reciprocal per cell forward rate 
constant, 1/(Acmrmlkf0), will the number of bonds become comparable to that of the total
reacting molecules. Because the number of receptors and ligands participating in binding 
is enormous, however, even a very small fraction of these represent many molecules. 
Therefore, bond formation must occur as soon as the two cell membranes are placed in 
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contact. Similarly, dissociation takes place immediately after bonds are formed, despite 
the fact that the fraction of bonds dissociated is small until the contact time is comparable 
to the reciprocal reverse rate constant, 1/kr0. In the transient phase of the n /Ac versus t
curve, bond formation outpaces bond dissociation, whereas the two processes reach an
equal rate in the plateau phase.
In small systems, by comparison, only a few or even no bond may form during 
the entire contact time, for one no longer has large numbers of molecules interacting 
simultaneously. As illustrated in Fig. 5.2a, bond formation may occur at any instant 
during the contact time, or it may not occur at all. Moreover, bonds formed at an earlier 
instant after the beginning of contact may dissociate at a later instant before the end of the 
contact. In any particular adhesion test, when an adhesion is detected during cell-cell 
separation, the experimenter does not know the precise moment in the contact period 
when the bonds are formed. Similarly, when no adhesion is detected, it is not known
whether this is a case in which the bonds formed at earlier instants have already 
dissociated, or it is the case in which there is no bond formation at all. Nevertheless, one 
thing is certain and measurable in repeated adhesion tests: the probability of adhesion and 
its changes with the contact time. Thus, from the probabilistic standpoint, it is the 
likelihood of bond formation (as opposed to bond formation itself) that outpaces the 
likelihood of bond dissociation (as opposed to bond dissociation itself) in the transient 
phase of the Pa versus t curve. In the plateau phase the changes in the two likelihoods 
reach an equal rate.
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Figure 5.2: (a) Three example realizations of the bond number, n, as a stochastic process 
in time, t, during the cell-cell contact. The changes in n appear as random jumps of unit 
step size that could take place at any instant. Either formation of a new bond (n is 
increased by 1) or dissociation of a preformed bond (n is decreased by 1) may occur. 
(Top) No bond formation occurred during the entire 5 s of contact duration. (Middle) A 
bond was formed at 2 s but dissociated at 4 s. In both cases, no adhesion was detected by 
the experimenter, and he would not be able to tell the different between the two. 
(Bottom) Two bonds were formed at the 1- and 3-s time points respectively. Adhesion 
was detected in the postcontact cell-cell separation phase at the end of the dead time (5.1-
s time point), after which the bond was broken by force at the 5.3-s time point. However, 
the experimenter would not know that more than one bond was formed, but one 
dissociated at the 4.5-s time point before the end of the contact duration. (b) Schematic of 
how the apparent contact area changes with time, indicating the definitions of lead time, 
contact duration, recovery time, and dead time. Note that the apparent contact area A*c
(=πD2/4, where D ≈ 2 µm is the apparent contact diameter measured from 
photomicrographs such as that shown in Fig. 3.1) is proportional, but not necessarily 
equal to the true contact area Ac. Also indicated is the instant at which the bond shown in 
the bottom panel of A was broken by force.
It should be noted that, in small systems appropriate for the probabilistic 
description, the time scales set forth by 1/(Acmrmlkf0) and 1/kr0 reflect the respective 
waiting times necessary for the events of bond formation and dissociation to occur, not 
the actual durations of these events. The physical processes during which the binding
pockets of the receptor and ligand fit into or break away from one another take place on a 
ba
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much shorter time scale (~ µs or even ns; Bell, 1978), as illustrated in Fig. 5.2a by 
instantaneous jumps. The waiting time is limited by diffusion (predominantly the 
rotational and orientational modes rather than the translational mode).
Effect Of Finite Time Requirement For Adhesion Detection
The beginning of the contact period is operationally defined as the instant when 
the piezo-driven micropipette first arrives at its pause position and stops motion (Fig. 
5.2b). At this moment, the contact area has achieved a plateau level; this is defined as Ac. 
To arrive at this finite contact area, however, requires a nonvanishing time (called lead 
time) that precedes the above-defined beginning instant of the contact period and which 
starts when the two cell membranes first come into point contact (Fig. 5.2b).
Similarly, the end of the contact period is operationally defined as the instant 
when the experimenter starts to pull the cells apart, but at this moment the cells are still in 
touch with one another (Fig. 5.2b). In a process that is the reversal of what occurred in the 
lead time, the RBC membrane gradually reassumes its uncompressed shape upon the 
removal of the impingement force (assuming that adhesion, if any, occurs at the apex); 
the time of this process is called the recovery time (Fig. 5.2 b).
Theoretical treatment of the variable contact area during the lead time and the 
recovery time is possible by replacing the constant Ac in Eq. 3-3 with a (given) function 
of time; but this will greatly increase the mathematical complexity of the analysis. Such a 
treatment seems not to be warranted, for the overall effect of not including in the analysis 
the lead time and recovery time must be minimal. Adhesions that occurred in the lead 
time would be included as adhesions that occurred during contact time. In contrast, bond 
formation and dissociation that occurred in the recovery time would not be included, as 
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they could not be detected by the experimenter. Thus the individual effects of excluding
the lead time and recovery time from analysis cancel one another.
The experimenter cannot tell whether adhesion has occurred until the RBC has 
been further withdrawn, resulting in either a deflection in its membrane (Fig. 3.1c or d) or 
a separation of its spherical outline from the CHO cell (Fig. 3.1b). This is also a process 
that takes nonvanishing time (called dead time) to accomplish. Formation of new 
adhesions during dead time is highly unlikely because of the vanishing contact area. 
However, bonds preformed during the contact time but dissociated in the dead time 
(probably at a faster rate because of the influence of force) cannot be counted. The effect 
of such a dead time is analyzed below.
Because 0.5/kr0 is the contact time needed for the adhesion probability to reach 
half-maximum, some of the Pa data ought to be measured in contact times shorter than 
0.5/kr0 for both kinetic rate constants (as opposed to just the binding affinity) to be 
resolved, as measurements at longer contact times where the adhesion probability levels 
off contain only equilibrium information. In the present work, 0.5/kr ≈ 1.4 and 2.5 s for 
CD16a binding to human and rabbit IgG, respectively. Two contact time points (0.5 and 1
s) shorter than 0.5/kr0 were used. The piezoelectric translator withdrew the micropipette at 
a speed of 10 µm/s. A 0.5-µm withdrawal, which is quite enough for the experimenter to 
determine whether adhesion has occurred, required only 0.05 s. Such a dead time is an 
order of magnitude shorter than the shortest contact duration and 30-50 times shorter than 
0.5/kr0. This ensures that the adhesion events that occurred during the dead time would be 
negligible compared to those that occurred during the contact time, validating the 
applicability of the presentmethod to the CD16a-IgG system.
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However, if the receptor-ligand interaction in question dissociates with a fast rate 
such that its 0.5/kr0 is comparable to the dead time, then bond dissociation becomes likely 
to occur in the dead time. This would result in an underestimation of the adhesion 
frequency if contact times comparable to 0.5/kr0 were used. To minimize such an effect, 
much longer contact times must be used to ensure that binding events that take place in
the contact time would remain dominant over those that occur in the dead time. 
Consequently, only steady-state, not transient data can be reliably measured, yielding 
only the binding affinity, not kinetic rate constants.
Thus it is of interest to reduce the dead time as much as possible. However, 
withdrawing the RBC too fast would induce significant hydrodynamic forces that deform 
the cell. Moreover, rapid deflections of the RBC would be resisted by the membrane 
viscosity in addition to elasticity. Both effects would reduce the sensitivity of the RBC 
force transducer. Using the Stokes equation, F = 6 RcV, the drag force F a spherical 
RBC (of radius Rc = 2.5 µm) experiences as it moves in a medium of viscosity  = 10 3
pN · s/µm2 at a speed of V = 10 µm/s can be found to be 0.5 pN, much smaller than the 
typical single bond strength. However, using a Voigt model for the RBC membrane with 
a membrane viscosity ηm ≈ 0.6-1.2 pN  s/µm (Hochmuth, (1987)), the viscous resistance 
to a 10 µm/s deformation rate would be 6-12 pN, on the same order of magnitude as the 
typical single bond strength. Indeed, we found that a pipette retraction speed much greater 
than 10 µm/s resulted in notable reduction of the frequency of detectable adhesions.
100
Effect Of Low Force Detection Limits
The value of the forward rate constant predicted by the present method depends 
on several factors. One of these is whether the adhesion probability estimate takes all 
positive adhesion scores into account. This requires that even a single receptor-ligand
bond be unambiguously detected. To achieve this ultrahigh level of sensitivity, the human 
red blood cell was used as the adhesion detector (Fig. 3.1). The micropipette aspirated 
RBC force transducer has been shown to be capable of detecting forces as low as 
subpiconewtons, which is orders of magnitude lower than the typical strength of a 
noncovalent receptor-ligand bond (Bell, (1978); Evans et al., (1991); Chesla and Zhu, 
(1996); Zhu and Chesla, (1997)). However, dissociation of such noncovalent receptor-
ligand bonds is a stochastic event that could occur at any force, even at zero force (Bell, 
(1978); Evans et al., (1991); Zhu and Chesla, (1997)). As such, there would always be a 
fraction of positive adhesions that are inevitably miscounted as false negative 
nonadhesions. The impact of this detection limit is examined below.
Let αn be the fraction that is miscounted in those adhesion events that are 
mediated by n bonds, because of the sensitivity cutoff of the adhesion detector. The 
relationships αn ≥ 0 and αn > αn+1 (n ≥ 1) must hold, as the more bonds that are involved
in the adhesion, the harder it is for it to dissociate at low force, and hence the smaller the 
miscounted fraction. For simplicity, the αn's are assumed to be parameterized as αn  = αn
(0 ≤ α < 1). This equation is probably not exact, but it should be a reasonable 
approximation. The advantage of using such a power law expression with a single 
parameter is that it enables a close-form solution. Discounting these fractions from the 
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"ideal" adhesion probability, Pai =  1 p0, the "actual" adhesion probability, Paa, detected 
by the experimenter, the one that ought to be used to fit the data, should be
Paa = Pai – αn pnΣn =1
∞





= 1 – exp{– (1 – α)A cmrmlKa0[1 – exp( – kr0t)]}
(5-2) 
It follows from Eq. 5-2 that, as a result of detection cutoff, the binding affinity 
(and thereby the forward rate constant) would be underestimated by a factor of 1 - α, 
whereas the reverse rate constant is not affected.
Effects Of Receptor And Ligand A vailability
Other factors affecting the value of kf0 (and Ka0) derived from the present work 
have to do with the availability of the receptors and ligands in the contact area. In contrast 
to kr0, which has the same unit (s 1) on both the per-cell and per-molecular density basis, 
the per molecular density kf0 (in µm2 s 1) was not computed directly from the fitting of 
the Pa versus t data. Instead, it was lumped into a per-cell forward binding rate constant, 
Acmrmlkf0 (s 1). To calculate kf0 from Acmrmlkf0 requires separate experiments to 
independently measure the densities of receptors, mr, and ligands, ml, as well as the 
contact area,Ac.
Two assays were employed in the present study to measure mr and ml: flow 
cytometry and radioimmunoassay. As can be seen in Fig. 4.1, either assay allowed for 
consistent quantification of CD16a expressed on CHO cells and IgG coated on RBCs. 
However, whereas soluble antibodies used in these assays could access all surface 
antigens, it is likely that ligands coating the RBCs were only able to access those 
receptors that were localized on the tips of the microvilli, but not those that were hidden 
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in the membrane folds of the rough surface of a CHO cell. It is not known whether the 
CD16a molecules are evenly distributed on the CHO cell surface, as are β2 integrins on 
neutrophils, or are concentrated on the microvilli tips, as are L-selectin and PSGL-1 on 
neutrophils (Hasslen et al., (1996)). Should it be the former case, the number of molecules 
capable of participating in binding ought to be its density (molecule per cell/total area per 
cell) times the area of the microvillus tips in the contact, not the apparent contact area. 
Taking an estimated 100% excess membrane over a spherical cell of radius 10 µm and 
assuming the microvilli to be cylinders 0.5 µm long and 0.1 µm in diameter, it can be 
estimated that only 2.5% of the apparent contact area measured from the 
photomicrograph (~3 µm2 in all experiments; cf. Fig. 3.1a) can be counted as true Ac.
Although the surface of a RBC is much smoother than that of a CHO cell, not all 
of the ligands necessarily have a proper orientation that is recognizable by the cell-bound 
receptors, as the chromium chloride method employed to coat the RBC surface with IgG 
is not specific. We have investigated this issue, and the details will be described 
elsewhere. Briefly, it was found that, of the ligands capable of interacting with soluble 
antibodies in the surface density determination (the values listed in Table 1 for ml), only a 
small fraction (~10-20%) are functioning in cell adhesion. The kinetic parameters 
reported in Table 4-1 and 4-2 were calculated assuming all IgG molecules detected by 
flow cytometry in site density determination were functioning; thus the values for kf0 (and 
Ka0) are underestimated.
In addition, the total human IgG used in this study includes all four subtypes, of 
which only two, hIgG1 and hIgG3, bind to CD16 (Nagarjan et al., (1995)). Because they 
comprise ~70% (hIgG1) and 5% (hIgG3), respectively, of the total hIgG, the kinetic rate
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constants calculated here are average properties of CD16a binding to the two subtypes of 
hIgG. Experiments are under way to measure the intrinsic kinetic properties of each 
subtypes of hIgG1 and hIgG3.
Despite the uncertainty associated with dissecting the per molecular density 
forward rate constant kf0, the values of the per-cell forward rate constant, Acmrmlkf0, and 
the reverse rate constant, kr0, should be unambiguous and directly relevant to predicting 
cellular behavior, as they were evaluated directly from the cell adhesion data. It is 
interesting to note that these two parameters are of the same order of magnitude as those 
measured for E-selectin/carbohydrate ligand binding by the flow chamber method 
(Kaplanski et al., (1993)). Because the kinetic rates are believed to determine whether the
receptor-ligand interaction is rapid enough to capture moving cells in the flow 
environment, we tested whether Fcγ receptors could mediate adhesion of flowing cells to 
a hIgG-coated surface. Preliminary results suggest that this is indeed the case (Wright,
(1997)).
Individual Molecular Features Of The M ethod
An interesting observation from Fig. 5.1 is the smallness of the average number of 
bonds ( n   < 1.5) that mediate the adhesion seen here. To further explore this low bond 
number feature, the Paa versus n  relationship (Eq. 5-2) was used to eliminate n  from Eq. 
3-5 to obtain a prediction for the bond distribution as a function of adhesion probability:
pn =
(1 – Paa)1/(1 – α)
n! ln
n(1 – Paa)
– 1/(1 – α) (5-3) 
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It can be seen from Fig. 5.3a that, even with the highest adhesion probability seen 
in our experiments, the number of bonds that have nonvanishing probabilities (≥0.01) is 
no more than five. If α = 0, p1 > pn for n > 1, even at Paa = 80%. For moderate and low 
adhesion probabilities, the bindings are mediated predominantly by single bond events, 
although this dominance is weakened somewhat as increases (Fig. 5.3b).
Figure 5.3:  Individual bond feature of the present method. (a) Probabilities of having the 
first five bonds, pn (n = 1-5), and (b) that of having single, p1, and multiple, Σn>1pn, bonds 
(right ordinate), as well as the ratio of the probability of having a single bond to that of 
having multiple bonds, p1/Σn>1pn, (left ordinate) as a function of the measured probability 




The above low bond number prediction is also consistent with the observation in 
the micropipette experiment that, although the two cells were allowed to touch each other 
via an apparent area of a few square microns during the contact period, only very few 
(usually only one if at all) spatially separate discrete attachment point(s) were observed 
when the contact was being separated (Fig. 3.1c and d). One might argue that it was still 
possible that multiple bonds were involved in these point attachments. For this to be the 
case, however, the receptors and ligands must either be multivalent or be presented on 
their respective cell surfaces as clusters, such that bonding of one binding site in the 
multivalent molecule (or one molecule in the cluster) dramatically increases the 
probability that the other binding sites in the same multivalent molecule (or other 
molecules in the same cluster) will bind, leading to the rapid formation of multiple bonds 
as a single unit in a discrete attachment point of vanishing area, despite the fact that the
odds of forming more new bonds in the rest of the contact area of much larger size 
remains low. The CD16a-IgG binding is monovalent, as shown in the Results and by 
Ghirlando et al. (1995). Furthermore, it is unlikely that both CD16a and IgG are clustered 
on their respective cell membranes. Thus, not only does our micropipette method measure 
the adhesion kinetics of individual cells; it also is very likely to probe the binding kinetics 
of individual molecules. It should be emphasized that the method does not require all 
adhesions to be single bond mediated, as the analysis utilizes not only single but also 
multiple bond events. In other words, the small fraction of multiple bond events 
contributes useful information, not noise, to the analysis.
A major goal of the present work was to compare the two-dimensional binding 
kinetics and affinities of two human CD16a membrane anchor isoforms for the Fc domain 
106
of IgG. Since adhesion of Fc receptor-expressing leukocytes to IgG-coated targets is an 
initiating step for many immune responses, the determination of CD16-IgG kinetic rate 
constants is important in both biological and clinical settings. Unlike typical hormone 
receptors that bind soluble ligands (i.e. three-dimensional binding kinetics), adhesion 
receptors bind membrane-bound ligands (i.e. two-dimensional adhesion kinetics). Clearly, 
it is the two-dimensional, rather than the three-dimensional, kinetic rate constants that are 
most relevant to physiological situations such as adhesion of a CD16a-expressing NK cell 
or macrophage to an antibody-coated target cell.
By applying the micropipette method developed in this thesis, an attempt was 
made to address the following biological questions. Did the membrane anchor (including 
the associated subunits) influence the kinetic rates? If so, what might be the mechanisms 
causing the observed changes? To address these questions, the effects of the extracellular
domain and the membrane anchor were isolated using the lipid-anchored CD16a-GPI
construct. CHO cell transfectants were used to obtain a uniform cellular background 
across the CD16 membrane isoforms expressed. Under these conditions, the membrane 
anchor effect was clearly revealed by the micropipette experiment (Figure 4.9). This is 
the first experimental demonstration of the membrane anchor effect on the kinetic rates.
The three-dimensional binding characteristics were also measured for the same 
interacting molecules (Figure 4.11) in order to elucidate the mechanism underlying the 
observed anchor effect. Because much work is available in the literature on three-
dimensional CD16-IgG interactions, comparison to those helps validate the two-
dimensional measurements and strengthen the conclusions. Indeed, the same trends for 
affinities were seen in both two-dimensional and three-dimensional measurements,
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indicating that the micropipette method is adequate for measuring structure-function 
relationship of cell-bound receptors.
Comparison To Published Results
Vance et al. (Vance et al. (1993)) reported a higher three-dimensional binding 
affinity for monomeric hIgG of CD16a on NK cells (3-10 × 106 M-1) than of CD16b on 
neutrophils (value not determined). The former is therefore referred to as an intermediate 
affinity receptor, whereas the latter is considered as a low affinity receptor. It was not 
demonstrated, however, to what degree this differing affinitywas due to the differences in 
the extracellular domain, in the membrane anchor, or in the cellular background of the 
two membrane isoforms. On the other hand, Tamm et al. (Tamm et al. (1996)) reported a 
similar three-dimensional avidity of CD16a-GPI and CD16bNA2, both expressed on a 
human embryonic kidney cell line 293, for heat-aggregated hIgG1 (~20×106 M-1). These 
authors suggested that the minor differences in the ectodomains of the two molecules 
(Figure 2.5b and c) would not affect their affinity, although their data showed an ~2-fold 
higher avidity of CD16a-GPI than CD16b for dimeric hIgG1 (3.7 and 2.1 × 106 M-1, 
respectively). In this work it was found that in our CHO cell system using hIgG and 
RbIgG, CD16a-GPI showed consistently higher affinity than CD16a-TM in both two-
dimensional (Table 4-2) and three-dimensional (Table 4-3) binding studies. Furthermore, 
repeated side-by- side experiments reproducibly showed that the order of three-
dimensional affinities for hIgG, hIgG1, and RbIgG was CD16a-GPI > CD16a-TM>
CD16bNA1 ~ CD16bNA2 (Table 4-3 and data not shown). The discrepancies in the absolute
values of three-dimensional affinities measured by the different laboratories might be due 
to cell type-specific glycosylation of CD16 (Edberg et al. (1997)). However, the data 
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acquired in this work were obtained using the same CHO cells to express various CD16 
membrane isoforms. These results appeared to indicate that in comparison to CD16a, the 
variations in the extracellular domains of the two CD16b alleles (Figure 2.5,b and c), 
although very small, did significantly reduce their affinities for hIgG and RbIgG (Table 
4-3) and for hIgG1 (data not shown). This is not surprising, as two independent single 
nucleotide polymorphisms (resulting in amino acid changes Leu-48 to Arg-48 or His-48 
and Val-176 to Phe-176) in CD16a have been reported to alter the affinity of IgG binding 
(de Hass et al. (1996),Wu et al. (1997)). The CD16a-TM and CD16a-GPI molecules used 
in the present study do not have these polymorphic variations (Kurosaki et al. (1989)), as 
confirmed by sequencing during subcloning of the CD16a-TM cDNA into the pcDNA3
vector.
Possible Role Of The Associated Subunits
Miller et al. (1996) suggested that the associated γ chain could enhance the ligand 
binding affinity of FcγR. They reported at least an order of magnitude higher three-
dimensional affinity of CD16a-TM than CD16a-GPI for mIgG2a. The affinity of CD16a-
TM for mIgG2a obtained by these authors (12 × 106 M-1) is much higher than the value 
obtained in our lab, which may be due to the differences in the cells and/or the γ chain 
used. Miller et al. (1996) used monkey kidney COS cells to express transiently human 
CD16a-TM in association with human γ chain. By comparison, results from our lab were 
obtained using stably transfected CHO cells to express human CD16a-TM in association
with rat γ chain. Furthermore, Miller et al. (1996) employed direct Scatchard analysis, 
whereas this work and our labs work used indirect competitive inhibition to measure 
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affinity. Nevertheless, we found the same trend as Miller et al. (1996) that CD16a-TM 
had higher affinity than CD16a-GPI for mIgG2a.
However, here this effect was ligand-dependent. For CLBFcgran-1, hIgG, and 
RbIgG, the trend inverted, with CD16a-TM having lower affinity than CD16a-GPI 
(Figures 4.9 and 4.11,a and b). These three-dimensional results were supported by those 
of the two- dimensional micropipette experiments, which involved direct visualization of 
over 20,000 controlled single cell pair adhesion tests. In addition, affinity measurements 
available in our lab showed that the chimeric molecules CD16a-γ and CD16a-ζ bound 
similarly to CD16a-TM but differently from CD16a-GPI for all ligands tested, including 
IgGs from three species and a mAb (Table 4-3) (Chesla, Li, Nagarajan, Selvaraj, Zhu 
(2000)). Thus, these findings indicate that the role of the associated subunit, if it is indeed 
the cause of the anchor effect, is not limited to the γ chain but also includes the ζ chain. 
Moreover, their putative role is not to enhance, but rather to alter, the ligand binding
affinity.
The Difference In Ligand Binding Kinetic Rates And Affinity Of CD16 Isoforms 
Cannot Be Explained By Their Differing Diffusivities
The GPI-anchored CD16 molecules (including both alleles of CD16b and the 
CD16a-GPI) exhibit a few folds faster translational diffusion on the CHO cell membrane 
than TM-anchored CD16a as determined by preliminary fluorescence recovery after 
photobleaching measurements (data not shown). In addition, the GPI anchor is likely to 
provide more flexibility to the ectodomain of the receptor, which increases its rotational 
diffusion coefficient, a parameter more relevant to enhancing two-dimensional binding 
than the translational diffusion coefficient. One should therefore consider whether the 
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faster binding of CD16a-GPI than CD16a-TM to hIgG and RbIgG could be explained by 
the diffusional difference of the two membrane anchor isoforms. However, the following 
three lines of reasoning argue against this explanation and allow us to rule it out as the 
cause for the different kinetic rates of CD16 anchor isoforms.
First, faster diffusion of CD16a-GPI cannot explain the observed effect of the GPI 
anchor on the forward, and the lack thereof on the reverse, rate constants (Table 4-2). 
Existing theories have shown that diffusion influences kf and kr similarly but not 
Ka = kf/kr, since the diffusion effects on the two rates cancel each other in the ratio (Bell 
(1978)). Second, the anchor effect was seen not only in the two-dimensional micropipette 
experiment, but also in the three-dimensional binding assays (Table 4-3) where identical 
but soluble ligands and the same CD16-expressing CHO cells were examined. Diffusion 
should not affect the three-dimensional results not only because it was the ratio Ka, not kf
or kr separately, that was measured but also because diffusion is unlikely to be the rate-
limiting step in the two-step binding process (the other step being intrinsic reaction). The 
diffusivity of proteins in fluid phase (>10 µm2/s) is usually orders of magnitude greater 
than cell surface proteins (Lauffenburger et al. (1993)). Finally, the diffusion mechanism 
cannot explain the inversion of the anchor effect; the faster diffusing CD16a-GPI bound 
with slower forward rate and lower affinity to mIgG2a than CD16a-TM (Tables 4-2 and 
4-3). This negative correlation between diffusion coefficient and forward rate/binding 
affinity provides direct and definitive experimental proof for the inability of the differing 
diffusivities to account for the CD16a anchor effect on kinetic rates and affinity.
It should be pointed out that in the micropipette experiment accumulation of 
receptors in the contact area by lateral diffusion is unlikely. The diffusion coefficients for 
111
various CD16 isoforms on CHO cells are of the order of 0.01 µm2/s (data not shown). 
The longest contact time in the micropipette experiments was 20 s, which was far from 
sufficient for the receptors to accumulate in an apparent contact area of ~3 µm2. 
Furthermore, only a few bonds were formed in an adhesion produced by the controlled 
contact in the micropipette experiments (Chesla et al. (1998)), which is a negligibly small 
number comparing to the hundreds and thousands of receptors in the contact area. This 
will not generate any appreciable density gradient of free receptors to drive them to 
diffuse into the contact area.
The Difference In Ligand Binding Kinetic Rates And Affinity Of CD16 Isoforms 
Cannot Be Explained By Their Differing Orientations And Lengths
The lack of TM and cytoplasmic domains as well as the associated subunits of the 
CD16a-GPI may alter the orientation of its extracellular domain. Moreover, the GPI 
moiety may extend the Fc binding epitope further outward relative to the glycocalyx
(Figure 2.5). The length of a receptor has been demonstrated to influence its ability to 
support adhesion at 4 °C (but the effect diminished at higher temperatures) (Chan et al. 
(1992)) and under flow (but not static) conditions (Patel et al. (1995)). It is thought that a 
longer and more flexible molecule can explore larger space above the membrane and 
assume more spatial configurations. This lengthens the interaction range of the receptor, 
thereby facilitating its effort to find the ligand when it is surface-linked (Wong et al. 
(1997)). However, although both orientation and length can influence ligand binding 
kinetic rates and affinity, this effect should be qualitatively monotonic for all ligands.
Therefore, the observation that the GPI anchor increases affinity for human and rabbit 
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IgGs but decreases affinity for murine IgG2a allow us to exclude orientation and length 
as possible causes for the anchor effect (Chesla, Li, Nagarajan, Selvaraj, Zhu (2000)).
The Difference In Ligand Binding Kinetic Rates And Affinity Of CD16 Isoforms 
Cannot Be Explained By Their Differential Distribution And Clustering
Some GPI-anchored proteins have been suggested to be clustered in 
glycosphingolipid and cholesterol-enriched domains, e.g. caveolae (Anderson et al. 
(1998)). CD16a-GPI might appear to bind better than CD16a-TM in the three-
dimensional assay should the former isoform be functionally clustered, since binding of 
aggregated soluble ligands to receptor clusters might result in an apparently higher
avidity.
Similarly, being distributed in different membrane domains might potentially 
influence the two-dimensional binding properties of CD16a-GPI. The forward rate kf and 
binding affinity Ka measured from the micropipette assay are lumped with the contact 
area Ac. The true or functional contact area Ac was not measured but should be 
proportional to the apparent contact area directly visible under the light microscope
(Figure 3.1) (Chesla et al. (1998)). The CHO cell surface displays extensive roughness;
thus only the "hills," not "valleys," of the membrane folds are likely to be part of the 
functional Ac. Since the same CHO cells were used to express CD16a regardless of the 
anchors and the same red blood cells were used to present IgG regardless of the species, 
Ac would be a constant if the apparent contact area was kept constant, as was the case in 
all of our experiments. Thus, not knowing the value of Ac or of which membrane 
microdomains it was composed should not affect conclusions based on relative 
comparisons, provided that the two CD16a membrane anchor isoforms were similarly 
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distributed in the contact area. However, while some adhesion molecules (e.g. β2
integrins) are more or less uniformly distributed on the cell surface, others (e.g. L-
selectin) are known to localize on the microvillous tips (Hasslen el al. (1996)). Because 
the latter molecules are present at higher densities on Ac, their kf and Ka values will be 
overestimated by a calculation that assumes a uniform molecular distribution. Thus, 
CD16a-GPI would appear to bind better than CD16a-TM should CD16a-GPI be 
differentially enriched on the hills (accessible area) or CD16a-TM be differentially 
enriched on the valleys (inaccessible area) of the membrane folds.
Although the arguments in the preceding paragraphs may seem consistent with 
the binding pattern seen in the human and rabbit IgG experiments, they cannot explain the 
inversion of that trend observed in the mIgG2a experiment. The differential distribution
and clustering of receptors should not flip when IgGs from different species were used as 
ligands to assay kinetics. Moreover, differential distribution of GPI- and TM-anchored 
CD16a should not affect the three-dimensional results, since the soluble ligands should be
able to access any membrane domains, and the calculation is based on average 
measurements over the entire cell surface, not particular compartmentalized domains. We 
thus conclude that the differences in ligand binding kinetic rates and affinity of CD16a 
isoforms are not due to their differential distribution and clustering.
No Major Differential Glycosylation Of CD16a Isoforms Can Account For The 
Anchor Dependence Of Ligand Binding Kinetic Rates And Affinity
GPI-anchored proteins may have different resident time and may hence be 
processed differently in the Golgi apparatus than TM- anchored proteins, resulting in 
different carbohydrate modifications. However, available analysis of CD16 isoforms 
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purified from CHO cells using SDS-PAGE did not reveal major differences in N-linked 
glycosylation. (Chesla, Li, Nagarajan, Selvaraj, Zhu (2000)). The ~4-kDa higher 
molecular mass of CD16a-TM than CD16a-GPI can be well accounted for by the 45
amino acid TM and cytoplasmic domains (~5.4 kDa) of the former isoform and the GPI 
moiety (~1 kDa) of the latter isoform. Of course, more extensive analysis is required to 
test whether site-specific differential glycosylation exists between the two CD16a 
membrane anchor isoforms and, if so, whether it is the cause of the observed anchor 
effects on kinetic rates and binding affinity.
Could The Difference Be Explained By Differing Conformations
A consequence of the possible concentration of CD16a-GPI in glycosphingolipid-
enriched membrane microdomains may be its being surrounded by different neighboring 
molecules. It is conceivable that neighboring molecules of CD16a-GPI could affect its 
ligand binding. But to affect binding in one way with hIgG, RbIgG, and mAb 
CLBFcgran-1 but in an opposite way with mIgG2a and mAb VEP13 would most likely 
require CD16a-GPI to associate with the neighboring molecules. Such an association 
would most likely have to be in sufficiently close proximity to render a conformational 
change of the receptor, resulting in variable accessibility by different ligands and mAbs. 
So far, only the myeloid cell-specific integrin αMβ2 has been reported to associate with 
the GPI-anchored CD16b (Poo et al. (1995)). CHO cells do not express β2 integrins. By 
comparison, in order for it to be expressed on the CHO cell surface CD16a-TM must be 
associated with the γ chain (Figure 2.5b). Such an association has been shown to alter the 
binding of not only CD16a but also CD64 (Fcγ receptor I) (Chesla et al. (1998)).
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Finally, an alternative and perhaps simpler hypothesis may be that the differing 
membrane anchors themselves, when they are inserted into the cell surface, yield such a 
conformational difference. The view that different conformations of the two CD16a 
isoforms may be the mechanism underlying their different kinetic rates and binding 
affinity is supported by the following resemblance between our observations and those 
commonly accepted as valid evidence for conformational change in integrins. Certain 
"activation-reporter" mAbs bind integrins only after they have been converted from 
resting to activated states, which is interpreted as a conformational change that allows for 
expression of antigenic epitopes that are specific to the activated conformer (Sanchez-
Mateos et al. (1996)). Another characteristic of conformational changes of integrins is 
changes in their abilities to bind soluble ligands and to mediate cell adhesion. The binding 
results are also available using another mAb (VEP13). VEP13 reacts strongly with 
CD16a-TM but only weakly with CD16a-GPI, suggesting that the epitope detected by 
mAb VEP13 is substantially down-regulated after the molecule's anchor has been
changed from TM to GPI. In addition, the abilities to bind soluble ligands (and the mAb 
CLBFcgran-1) and to mediate cell adhesion are different for the two CD16a membrane 
isoforms, which are caused by their different kinetic rates and binding affinities for 
ligands (and for mAb CLBFcgran-1) (Chesla, Li, Nagarajan, Selvaraj, Zhu (2000)).
Similarly, Kukulansky et al. (1999) reported that following anchor cleavage by 
phospholipase C, the reactivity of the solubilized Thy-1 with several mAbs is lost, and its 
reactivity with polyclonal anti-Thy-1 antibodies is markedly decreased. These authors 
interpreted their finding by a GPI anchor-dependent conformational change of the Thy-1 
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molecule. Thus, the data presented in this thesis strongly suggests that replacement of 
polypeptide anchor with GPI anchor resulted in a conformational change of CD16a
The diversity of Fc receptors in both structure and function has long been 
appreciated (van de Winkel (1996)). The ability of Fc receptors to bind ligand has been 
shown to be influenced by a variety of structural variations. In this study we measured 
both two-dimensional kinetic rates and three-dimensional affinities of FcγRIII membrane
isoforms for various ligands, and we showed that the membrane anchor had an effect on 
these binding properties, which is likely caused by a conformational difference between 
the two CD16a membrane isoforms. These findings provide insights into the biological
significance of distinct anchors of cell surface proteins.
Resolution Of Force And Detachment Mode
Recently, there has been an increasing interest n measuring the interaction forces 
between cell adhesion receptors and their ligands (Evans et al. (1991) Florin et al. (1994), 
Zhu and Chesla (1997)). These molecules are either anchored on the membrane of a cell 
or coated on the surface of a substratum. The two surfaces are joined together as a result 
of the formation of non-covalent bonds between the receptors and ligands. The forces are 
measured when the two surfaces are separated. As previously stated in Chapter 2 
(Background / Literature) Bell (1978) calculated the force to rapidly break a single 
CD16/IgG type bond in the order of 1.2 pN per bond. The force that he calculated to 
uproot a receptor that is not anchored to the cytoskeleton was estimated at 1.0 pN per 
molecule, which is the same order of magnitude. The interpretation of the force data 
therefore requires the knowledge of detachment mode, i.e., via adhesive mechanism if the 
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receptor-ligand bond is dissociated or via cohesive mechanism if the receptor-membrane 
anchor is disrupted.
In this thesis, a simple micropipette assay was developed to measure the force and 
kinetics of Fcγ receptor III (CD16) binding to its ligands. It was noted that the running 
average of adhesion scores (Figure 4.14) in a series of repeated adhesion attempts 
(performed on the same contact area on the same pair of cells) exhibited different 
characteristics. Depending on the types of bonds and membrane anchors, either stable or 
declining running adhesion frequencies might be observed; here the suggestion is made 
that the latter is an indication for receptor uprooting.
In the results section the statistical analysis of the running adhesion frequency was
presented that enabled measurement of the extraction probability of a receptor from the 
cell membrane. The idea was since the force to break a bond is a random variable, 
whether the detachment of a particular receptor-ligand crossbridge results in receptor 
extraction also is stochastic. Nevertheless, a defined probability of such an event exists 
and it reflects the relative strengths of the receptor-ligand bond and the membrane 
anchor. In this experimental system IgG or IgM is covalently bound to RBC membrane 
proteins using a CrCl3 protocol. Given this, it is more likely that if one of the molecular 
agents is uprooted, CD16 on the CHO cell surface would be more likely suspected, 
especially if it is GPI anchored.
Each adhesion test can be modeled as a Bernoulli trial of two possible outcomes: 
the adhesion score (a random variable). If there are mr receptors available before the test, 
each is independent to the others and all have an equal probability to bind a ligand. For 
each of the bonds formed there is an equal probability, I, of receptor extraction at 
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detachment. Since the sequential repeated adhesion tests are a random process, statistical 
flucuations among individual realizations (measurements obtained with different cell 
pairs) are inevitable even if the underlying mechanism is the same. It is therefore 
important to look at isolated examples in order to draw conclusions about the detachment 
mechanism. As can be seen in Figure 4.14, the ligand type had a strong effect on the 
probability of receptor extraction, i.e., the anti-CD16 mAb mediated binding was found 
to exhibit a much higher probability of cohesive detachment (uprooting) than the Fc 
mediated binding. In addition, in the case of antigen-antibody binding the receptor type 
was found to have an influence: the I value for the GPI-CD16 was higher than that for the 
TM-CD16 suggesting an easier extraction for the GPI anchored receptor. As expected, no 
effect of the receptor anchor was found in the case of the Fc- FcR bond, consistent with 
the adhesive mode of detachment hypothesis.
This model enables quantitiative evaluation of the probability of receptor 
extraction from the cell membrane using data from repeated adhesion tests. Measuring 
this probability and correlating it with various types of receptor-ligand bonds and 
membrane anchors provides insight into the structure-function relationship of the 




SUMMARY AND RECOMMENDATIONS FOR FUTURE WORK
A novel method has been developed in this work to determine the 2D binding 
kinetics. The assay is designed to measure the adhesion probability using the micropipette 
method. Although the protocol was illustrated by the micropipette technique in this work, 
it can be adaptable to other techniques. The method was validated utilizing a CD16a-TM 
and human IgG experimental design and systematic strategies were developed to 
determine the kinetic mechanism and the associated rate constants of the binding reaction. 
Although the method is interesting and has merit in the fact that 2D kinetic rate 
determination is of scientific value, a broader affirmation of its merit was and is sought.
As previously stated CD16 is one of only four eukaryotic receptors known to exist 
natively in both the transmembrane (TM, CD16a) and glycosylphosphatidylinositol (GPI, 
CD16b) isoforms. The biological significance of this anchor isoform coexistence is not 
clear. Here we showed that the anchor influenced kinetic rates; compared with CD16a-
TM, CD16a-GPI bound faster and with higher affinities to human and rabbit IgGs but 
slower and with lower affinity to murine IgG2a. The same differential affinity patterns 
were observed using soluble IgG ligands. The evidence suggests a conformational 
difference as the mechanism underlying the observed anchor effect, as it cannot be 
explained by the differing diffusivity, flexibility, orientation, height, distribution, or 
clustering of the two molecules on the cell membrane. These data demonstrate that a 
covalent modification of an Ig superfamily receptor at the carboxyl terminus of the
ectodomain can have an impact on ligand binding kinetics. The method was utilized to 
determine the 2D kinetic rates of CHO cell expressed CD16a-TM, CD16a-GPI, 
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CD16bNA1 and CD16bNA2 during interaction with Red Cell bound human IgG. By 
comparing these rates as well as the 3D binding affinities determined using soluble 
human IgG, the effect different CD16 anchor mechanisms (TM versus GPI) was 
elucidated.
As stated previously, the theory utilized here to determine the kinetic rates of 
reaction utilizing the micropipette technique can be modified to other experimental 
methodologies. Usually, cell adhesion assays measure either the probability or the 
strength of adhesion. In population based studies this result translates into the fraction of 
adherent cells or the force dependence of the detached fraction of cells. A commercial 
population based cell adhesion assay was reported in Chapter 2 and described in Figure 
2.3. This assay measures the adhesion probability of antibody coated human RBCs to a 
substrate of variable antigen coating. As shown, the substrate is formed on the bottom of 
96 well, “U” bottom wells. The end result of the assay is a determination of whether the 
substrate is coated with or not coated with antigen. Because the red cell adhesion in this 
assay is mediated by the formation of antibody-antigen bonds, and as such the adhesion 
probability and strength must relate to the force dependence of binding affinity of the 
adhesion molecules, the molecular binding characteristics should be readily derived form 
the adhesion data. Such models are readily available in literature for similar experimental 
systems. Piper et al. (1998) describes a similar experimental system involving a 
population based cell adhesion assay which is also performed in 96 flat well system. In 
the flat well experimental system, the cells are first allowed to adhere to the substrate 
bottom then detachment is encouraged by centrifugation of the cells away from the well 
bottom. The experimental system shown in Figure 2.3 is slightly different with the red 
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cell attachment and detachment being simultaneously encouraged by a single 
centrifugation step. Nevertheless, the experimental model introduced by Piper (1998) 
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